| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | SOX1 ALX3 SOX9 SOX10 ZNF219 GATA2 GATA6 IRF7 POU4F1 NKX2-6 KLF4 ZNF446 ZIC3 MEOX1 USF3 SAFB SOX21 DACH2 NFATC2 NKX2-1 GLI3 ZNF589 TBR1 PROX1 | 1.46e-06 | 1459 | 112 | 24 | GO:0000977 |
| GeneOntologyMolecularFunction | benzodiazepine receptor binding | 1.70e-06 | 5 | 112 | 3 | GO:0030156 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | SOX1 ALX3 SOX9 SOX10 ZNF219 GATA2 GATA6 IRF7 POU4F1 NKX2-6 KLF4 ZNF446 ZIC3 MEOX1 USF3 SOX21 DACH2 NFATC2 NKX2-1 GLI3 ZNF589 TBR1 PROX1 | 2.97e-06 | 1412 | 112 | 23 | GO:0000981 |
| GeneOntologyMolecularFunction | chromatin binding | SOX9 SOX10 ARID3A GATA2 GATA6 POU4F1 KLF4 MEOX1 CITED2 NCOR2 SAFB NFATC2 GLI3 AUTS2 ANKRD17 TBR1 | 3.65e-06 | 739 | 112 | 16 | GO:0003682 |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | SOX9 SOX10 TRIP6 GATA2 GATA6 SIK1 POU4F1 BCL2 KLF4 CITED2 NCOR2 NKX2-1 MED13 PROX1 | 4.76e-06 | 582 | 112 | 14 | GO:0140297 |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | SOX1 SOX9 SOX10 ZNF219 GATA2 GATA6 IRF7 POU4F1 NKX2-6 KLF4 ZNF446 ZIC3 MEOX1 SAFB SOX21 DACH2 NFATC2 NKX2-1 GLI3 TBR1 PROX1 | 5.00e-06 | 1244 | 112 | 21 | GO:0000978 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | SOX1 SOX9 SOX10 ZNF219 GATA2 GATA6 IRF7 POU4F1 NKX2-6 KLF4 ZNF446 ZIC3 MEOX1 SAFB SOX21 DACH2 NFATC2 NKX2-1 GLI3 TBR1 PROX1 | 6.97e-06 | 1271 | 112 | 21 | GO:0000987 |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | SOX1 SOX9 SOX10 GATA2 POU4F1 NKX2-6 KLF4 ZIC3 MEOX1 USF3 SOX21 NFATC2 NKX2-1 | 1.55e-05 | 560 | 112 | 13 | GO:0001228 |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | SOX1 SOX9 SOX10 GATA2 POU4F1 NKX2-6 KLF4 ZIC3 MEOX1 USF3 SOX21 NFATC2 NKX2-1 | 1.74e-05 | 566 | 112 | 13 | GO:0001216 |
| GeneOntologyMolecularFunction | transcription factor binding | SOX9 SOX10 TRIP6 GATA2 GATA6 SIK1 POU4F1 BCL2 KLF4 CITED2 NCOR2 NFATC2 NKX2-1 MED13 PROX1 | 2.02e-05 | 753 | 112 | 15 | GO:0008134 |
| GeneOntologyMolecularFunction | beta-catenin binding | 5.92e-05 | 120 | 112 | 6 | GO:0008013 | |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | TRIP6 GATA2 GATA6 POU4F1 KLF4 CITED2 NCOR2 NKX2-1 MED13 PROX1 | 1.21e-04 | 417 | 112 | 10 | GO:0061629 |
| GeneOntologyMolecularFunction | transcription coregulator activity | ARID3A ATN1 SF1 ZIC3 CITED2 KMT2C NCOR2 NKX2-1 MED22 DYRK1B MED13 | 3.21e-04 | 562 | 112 | 11 | GO:0003712 |
| GeneOntologyMolecularFunction | LBD domain binding | 6.43e-04 | 7 | 112 | 2 | GO:0050693 | |
| GeneOntologyMolecularFunction | protein serine kinase activity | 1.02e-03 | 363 | 112 | 8 | GO:0106310 | |
| GeneOntologyMolecularFunction | transcription coactivator activity | 1.61e-03 | 303 | 112 | 7 | GO:0003713 | |
| GeneOntologyMolecularFunction | protein phosphatase 2A binding | 1.68e-03 | 42 | 112 | 3 | GO:0051721 | |
| GeneOntologyMolecularFunction | protein serine/threonine/tyrosine kinase activity | 2.33e-03 | 47 | 112 | 3 | GO:0004712 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | SOX1 CDK8 SOX9 SOX10 ZNF219 ARID3A GATA2 DVL3 GATA6 IRF7 POU4F1 NKX2-6 KLF4 MAP3K1 ZIC3 MEOX1 CITED2 KMT2C USF3 SAFB SOX21 NFATC2 NKX2-1 GLI3 MED22 AUTS2 TBR1 MED13 PROX1 | 1.94e-10 | 1390 | 112 | 29 | GO:0045944 |
| GeneOntologyBiologicalProcess | hindbrain development | CACNA1A USP9X GATA2 POU4F1 BCL2 NCOR2 PIANP SCN5A ULK1 TBR1 PROX1 | 1.82e-08 | 208 | 112 | 11 | GO:0030902 |
| GeneOntologyBiologicalProcess | neuron fate commitment | 3.43e-08 | 91 | 112 | 8 | GO:0048663 | |
| GeneOntologyBiologicalProcess | head development | SOX1 CACNA1A SOX9 USP9X GATA2 DVL3 POU4F1 BCL2 NKX2-6 AXIN1 ZIC3 NCOR2 PIANP SOX21 NKX2-1 GLI3 SCN5A ULK1 TBR1 PROX1 | 1.04e-07 | 919 | 112 | 20 | GO:0060322 |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | SOX1 SOX9 SOX10 ZNF219 ATN1 USP9X GATA2 GATA6 SIK1 IRF7 POU4F1 KLF4 CITED2 NCOR2 SOX21 NFATC2 NKX2-1 GLI3 ZNF589 SAP130 PROX1 | 2.05e-07 | 1053 | 112 | 21 | GO:0000122 |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | SOX1 SOX9 SOX10 ZNF219 ATN1 USP9X GATA2 GATA6 SIK1 IRF7 POU4F1 KLF4 SF1 AXIN1 CITED2 NCOR2 SOX21 NFATC2 NKX2-1 GLI3 ZNF589 TBR1 SAP130 PROX1 | 3.86e-07 | 1399 | 112 | 24 | GO:0045892 |
| GeneOntologyBiologicalProcess | chordate embryonic development | ALX3 SOX9 SOX10 TRIP6 USP9X GATA2 DVL3 GATA6 NKX2-6 CUBN KLF4 AXIN1 ZIC3 MEOX1 CITED2 NCOR2 GLI3 USPL1 PROX1 | 3.98e-07 | 906 | 112 | 19 | GO:0043009 |
| GeneOntologyBiologicalProcess | central nervous system development | SOX1 CACNA1A SOX9 SOX10 ATN1 USP9X GATA2 DVL3 POU4F1 BCL2 NKX2-6 ZIC3 CITED2 NCOR2 PIANP SOX21 NKX2-1 GLI3 SCN5A ULK1 TBR1 PROX1 | 4.07e-07 | 1197 | 112 | 22 | GO:0007417 |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | SOX1 SOX9 SOX10 ZNF219 ATN1 USP9X GATA2 GATA6 SIK1 IRF7 POU4F1 KLF4 SF1 AXIN1 CITED2 NCOR2 SOX21 NFATC2 NKX2-1 GLI3 ZNF589 TBR1 SAP130 PROX1 | 4.62e-07 | 1413 | 112 | 24 | GO:1902679 |
| GeneOntologyBiologicalProcess | embryo development ending in birth or egg hatching | ALX3 SOX9 SOX10 TRIP6 USP9X GATA2 DVL3 GATA6 NKX2-6 CUBN KLF4 AXIN1 ZIC3 MEOX1 CITED2 NCOR2 GLI3 USPL1 PROX1 | 5.81e-07 | 929 | 112 | 19 | GO:0009792 |
| GeneOntologyBiologicalProcess | brain development | SOX1 CACNA1A USP9X GATA2 DVL3 POU4F1 BCL2 NKX2-6 ZIC3 NCOR2 PIANP SOX21 NKX2-1 GLI3 SCN5A ULK1 TBR1 PROX1 | 8.45e-07 | 859 | 112 | 18 | GO:0007420 |
| GeneOntologyBiologicalProcess | limbic system development | 1.02e-06 | 141 | 112 | 8 | GO:0021761 | |
| GeneOntologyBiologicalProcess | forebrain generation of neurons | 1.43e-06 | 65 | 112 | 6 | GO:0021872 | |
| GeneOntologyBiologicalProcess | metencephalon development | 1.89e-06 | 153 | 112 | 8 | GO:0022037 | |
| GeneOntologyBiologicalProcess | cell fate commitment | SOX1 SOX9 GATA2 GATA6 POU4F1 BCL2 KLF4 NKX2-1 GLI3 TBR1 PROX1 | 2.34e-06 | 338 | 112 | 11 | GO:0045165 |
| GeneOntologyBiologicalProcess | forebrain development | SOX1 USP9X GATA2 POU4F1 NKX2-6 ZIC3 NCOR2 PIANP NKX2-1 GLI3 SCN5A TBR1 PROX1 | 2.56e-06 | 489 | 112 | 13 | GO:0030900 |
| GeneOntologyBiologicalProcess | central nervous system neuron differentiation | 2.88e-06 | 217 | 112 | 9 | GO:0021953 | |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | SOX1 ALX3 SOX9 XIRP1 GATA2 DVL3 GATA6 NTNG1 POU4F1 BCL2 AXIN1 ZIC3 CITED2 NCOR2 NKX2-1 GLI3 SCN5A TBR1 MMP13 SOD1 PROX1 | 4.13e-06 | 1269 | 112 | 21 | GO:0009887 |
| GeneOntologyBiologicalProcess | forebrain neuron differentiation | 1.01e-05 | 53 | 112 | 5 | GO:0021879 | |
| GeneOntologyBiologicalProcess | gland development | SOX9 SOX10 CD2AP GATA2 GATA6 BCL2 ZIC3 CITED2 NCOR2 NKX2-1 GLI3 SOD1 PROX1 | 1.06e-05 | 558 | 112 | 13 | GO:0048732 |
| GeneOntologyBiologicalProcess | cerebellum development | 1.09e-05 | 139 | 112 | 7 | GO:0021549 | |
| GeneOntologyBiologicalProcess | forebrain neuron fate commitment | 1.28e-05 | 9 | 112 | 3 | GO:0021877 | |
| GeneOntologyBiologicalProcess | heart development | SOX9 XIRP1 RPS6KA2 DVL3 GATA6 SIK1 POU4F1 NKX2-6 ZIC3 CITED2 NCOR2 GLI3 SCN5A MMP13 PROX1 | 1.48e-05 | 757 | 112 | 15 | GO:0007507 |
| GeneOntologyBiologicalProcess | sensory organ morphogenesis | 1.79e-05 | 343 | 112 | 10 | GO:0090596 | |
| GeneOntologyBiologicalProcess | digestive tract development | 1.95e-05 | 152 | 112 | 7 | GO:0048565 | |
| GeneOntologyBiologicalProcess | lung epithelium development | 2.01e-05 | 61 | 112 | 5 | GO:0060428 | |
| GeneOntologyBiologicalProcess | embryonic organ morphogenesis | 2.18e-05 | 351 | 112 | 10 | GO:0048562 | |
| GeneOntologyBiologicalProcess | neuron migration | 2.54e-05 | 218 | 112 | 8 | GO:0001764 | |
| GeneOntologyBiologicalProcess | cell differentiation in hindbrain | 2.63e-05 | 32 | 112 | 4 | GO:0021533 | |
| GeneOntologyBiologicalProcess | hippocampus development | 2.73e-05 | 108 | 112 | 6 | GO:0021766 | |
| GeneOntologyBiologicalProcess | negative regulation of developmental process | SOX9 SOX10 GATA2 BCL2 KLF4 AXIN1 CITED2 NCOR2 USF3 SOX21 NFATC2 ZFP36L2 NKX2-1 GLI3 ANKRD17 ULK1 SAP130 SOD1 PROX1 | 2.95e-05 | 1220 | 112 | 19 | GO:0051093 |
| GeneOntologyBiologicalProcess | developmental growth | SOX9 SOX10 XIRP1 ATN1 USP9X CD2AP GATA6 BCL2 CITED2 KMT2C GLI3 AUTS2 ULK1 MMP13 SOD1 PROX1 | 3.28e-05 | 911 | 112 | 16 | GO:0048589 |
| GeneOntologyBiologicalProcess | growth | SOX9 SOX10 XIRP1 ATN1 OGFR USP9X CD2AP PAK5 GATA6 BCL2 CITED2 KMT2C SAFB GLI3 AUTS2 ULK1 MMP13 SOD1 PROX1 | 3.49e-05 | 1235 | 112 | 19 | GO:0040007 |
| GeneOntologyBiologicalProcess | development of primary sexual characteristics | 3.54e-05 | 297 | 112 | 9 | GO:0045137 | |
| GeneOntologyBiologicalProcess | digestive system development | 3.57e-05 | 167 | 112 | 7 | GO:0055123 | |
| GeneOntologyBiologicalProcess | peptidyl-threonine phosphorylation | 3.90e-05 | 115 | 112 | 6 | GO:0018107 | |
| GeneOntologyBiologicalProcess | male gonad development | 4.15e-05 | 171 | 112 | 7 | GO:0008584 | |
| GeneOntologyBiologicalProcess | sensory organ development | SOX1 SOX9 GATA2 DVL3 BCL2 NKX2-6 KLF4 MAP3K1 ZIC3 CITED2 KMT2C GLI3 SOD1 PROX1 | 4.16e-05 | 730 | 112 | 14 | GO:0007423 |
| GeneOntologyBiologicalProcess | neuromuscular synaptic transmission | 4.24e-05 | 36 | 112 | 4 | GO:0007274 | |
| GeneOntologyBiologicalProcess | development of primary male sexual characteristics | 4.31e-05 | 172 | 112 | 7 | GO:0046546 | |
| GeneOntologyBiologicalProcess | stem cell differentiation | 4.47e-05 | 306 | 112 | 9 | GO:0048863 | |
| GeneOntologyBiologicalProcess | ventral spinal cord interneuron differentiation | 5.43e-05 | 14 | 112 | 3 | GO:0021514 | |
| GeneOntologyBiologicalProcess | peptidyl-threonine modification | 6.22e-05 | 125 | 112 | 6 | GO:0018210 | |
| GeneOntologyBiologicalProcess | heart morphogenesis | 6.46e-05 | 321 | 112 | 9 | GO:0003007 | |
| GeneOntologyBiologicalProcess | cardiac muscle tissue development | 7.45e-05 | 327 | 112 | 9 | GO:0048738 | |
| GeneOntologyBiologicalProcess | sensory system development | SOX1 SOX9 POU4F1 BCL2 KLF4 MAP3K1 CITED2 KMT2C GLI3 ULK1 PROX1 | 7.50e-05 | 491 | 112 | 11 | GO:0048880 |
| GeneOntologyBiologicalProcess | neuron fate specification | 7.86e-05 | 42 | 112 | 4 | GO:0048665 | |
| GeneOntologyBiologicalProcess | lung cell differentiation | 7.86e-05 | 42 | 112 | 4 | GO:0060479 | |
| GeneOntologyBiologicalProcess | lung epithelial cell differentiation | 7.86e-05 | 42 | 112 | 4 | GO:0060487 | |
| GeneOntologyBiologicalProcess | telencephalon development | 8.36e-05 | 332 | 112 | 9 | GO:0021537 | |
| GeneOntologyBiologicalProcess | embryo development | ALX3 SOX9 SOX10 TRIP6 USP9X GATA2 DVL3 GATA6 NKX2-6 CUBN KLF4 AXIN1 ZIC3 MEOX1 CITED2 NCOR2 GLI3 USPL1 SOD1 PROX1 | 8.59e-05 | 1437 | 112 | 20 | GO:0009790 |
| GeneOntologyBiologicalProcess | regulation of miRNA transcription | 8.94e-05 | 83 | 112 | 5 | GO:1902893 | |
| GeneOntologyBiologicalProcess | miRNA transcription | 9.47e-05 | 84 | 112 | 5 | GO:0061614 | |
| GeneOntologyBiologicalProcess | response to transforming growth factor beta | 1.07e-04 | 343 | 112 | 9 | GO:0071559 | |
| GeneOntologyBiologicalProcess | male sex differentiation | 1.08e-04 | 199 | 112 | 7 | GO:0046661 | |
| GeneOntologyBiologicalProcess | epithelium development | SOX9 SOX10 CD2AP GATA2 DVL3 GATA6 BCL2 NKX2-6 KLF4 MAP3K1 ZIC3 MEOX1 CITED2 NCOR2 SOX21 NKX2-1 GLI3 RCN3 SOD1 PROX1 | 1.16e-04 | 1469 | 112 | 20 | GO:0060429 |
| GeneOntologyBiologicalProcess | striated muscle tissue development | 1.22e-04 | 349 | 112 | 9 | GO:0014706 | |
| GeneOntologyBiologicalProcess | sex differentiation | 1.30e-04 | 352 | 112 | 9 | GO:0007548 | |
| GeneOntologyBiologicalProcess | anatomical structure formation involved in morphogenesis | CACNA1A SOX9 XIRP1 ZNF219 GATA2 DVL3 GATA6 KLF4 AXIN1 ZIC3 MEOX1 CITED2 NFATC2 NKX2-1 GLI3 DYRK1B ULK1 TBR1 USPL1 PROX1 | 1.32e-04 | 1483 | 112 | 20 | GO:0048646 |
| GeneOntologyBiologicalProcess | cerebellar cortex morphogenesis | 1.33e-04 | 48 | 112 | 4 | GO:0021696 | |
| GeneOntologyBiologicalProcess | glandular epithelial cell differentiation | 1.38e-04 | 91 | 112 | 5 | GO:0002067 | |
| GeneOntologyBiologicalProcess | cell fate determination | 1.56e-04 | 50 | 112 | 4 | GO:0001709 | |
| GeneOntologyBiologicalProcess | ear development | 1.66e-04 | 285 | 112 | 8 | GO:0043583 | |
| GeneOntologyBiologicalProcess | club cell differentiation | 1.74e-04 | 4 | 112 | 2 | GO:0060486 | |
| GeneOntologyBiologicalProcess | axon development | CACNA1A USP9X CD2AP NTNG1 POU4F1 BCL2 KLF4 NKX2-1 GLI3 AUTS2 ULK1 TBR1 | 1.93e-04 | 642 | 112 | 12 | GO:0061564 |
| GeneOntologyBiologicalProcess | gonad development | 1.95e-04 | 292 | 112 | 8 | GO:0008406 | |
| GeneOntologyBiologicalProcess | ear morphogenesis | 1.96e-04 | 154 | 112 | 6 | GO:0042471 | |
| GeneOntologyBiologicalProcess | pallium development | 2.12e-04 | 222 | 112 | 7 | GO:0021543 | |
| GeneOntologyBiologicalProcess | muscle tissue development | SOX9 XIRP1 GATA6 SIK1 POU4F1 BCL2 NKX2-6 ZIC3 CITED2 SCN5A PROX1 | 2.29e-04 | 558 | 112 | 11 | GO:0060537 |
| GeneOntologyBiologicalProcess | embryonic organ development | ALX3 SOX9 GATA2 DVL3 NKX2-6 AXIN1 ZIC3 CITED2 GLI3 SOD1 PROX1 | 2.40e-04 | 561 | 112 | 11 | GO:0048568 |
| GeneOntologyBiologicalProcess | regulation of miRNA metabolic process | 2.47e-04 | 103 | 112 | 5 | GO:2000628 | |
| GeneOntologyBiologicalProcess | axonogenesis | CACNA1A USP9X CD2AP NTNG1 POU4F1 BCL2 NKX2-1 GLI3 AUTS2 ULK1 TBR1 | 2.59e-04 | 566 | 112 | 11 | GO:0007409 |
| GeneOntologyBiologicalProcess | ventral spinal cord development | 2.61e-04 | 57 | 112 | 4 | GO:0021517 | |
| GeneOntologyBiologicalProcess | respiratory system development | 2.62e-04 | 305 | 112 | 8 | GO:0060541 | |
| GeneOntologyBiologicalProcess | circulatory system development | SOX9 XIRP1 RPS6KA2 GATA2 DVL3 GATA6 SIK1 POU4F1 NKX2-6 KLF4 ZIC3 CITED2 NCOR2 NFATC2 GLI3 SCN5A ANKRD17 MMP13 PROX1 | 2.67e-04 | 1442 | 112 | 19 | GO:0072359 |
| GeneOntologyBiologicalProcess | negative regulation of cell differentiation | SOX9 SOX10 GATA2 AXIN1 NCOR2 USF3 SOX21 NFATC2 ZFP36L2 NKX2-1 GLI3 ANKRD17 ULK1 PROX1 | 2.79e-04 | 875 | 112 | 14 | GO:0045596 |
| GeneOntologyBiologicalProcess | positive regulation of chondrocyte differentiation | 2.90e-04 | 24 | 112 | 3 | GO:0032332 | |
| GeneOntologyBiologicalProcess | skin epidermis development | 2.94e-04 | 166 | 112 | 6 | GO:0098773 | |
| GeneOntologyBiologicalProcess | stem cell population maintenance | 3.15e-04 | 237 | 112 | 7 | GO:0019827 | |
| GeneOntologyBiologicalProcess | cerebellum morphogenesis | 3.18e-04 | 60 | 112 | 4 | GO:0021587 | |
| GeneOntologyBiologicalProcess | atrial cardiac muscle tissue development | 3.29e-04 | 25 | 112 | 3 | GO:0003228 | |
| GeneOntologyBiologicalProcess | maintenance of cell number | 3.57e-04 | 242 | 112 | 7 | GO:0098727 | |
| GeneOntologyBiologicalProcess | cell differentiation in spinal cord | 3.83e-04 | 63 | 112 | 4 | GO:0021515 | |
| GeneOntologyBiologicalProcess | in utero embryonic development | SOX10 USP9X GATA2 GATA6 CUBN KLF4 AXIN1 CITED2 NCOR2 GLI3 USPL1 | 4.01e-04 | 596 | 112 | 11 | GO:0001701 |
| GeneOntologyBiologicalProcess | negative regulation of apoptotic process | CACNA1A SOX9 SOX10 CD2AP PAK5 GATA2 GATA6 IRF7 POU4F1 BCL2 NKX2-6 KLF4 CITED2 GLI3 CPEB4 SOD1 | 4.06e-04 | 1133 | 112 | 16 | GO:0043066 |
| GeneOntologyBiologicalProcess | hindbrain morphogenesis | 4.07e-04 | 64 | 112 | 4 | GO:0021575 | |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | CACNA1A USP9X CD2AP DVL3 NTNG1 GAS7 POU4F1 BCL2 NKX2-1 GLI3 AUTS2 ULK1 TBR1 | 4.12e-04 | 802 | 112 | 13 | GO:0048812 |
| GeneOntologyBiologicalProcess | negative regulation of transforming growth factor beta1 production | 4.32e-04 | 6 | 112 | 2 | GO:0032911 | |
| GeneOntologyBiologicalProcess | commitment of neuronal cell to specific neuron type in forebrain | 4.32e-04 | 6 | 112 | 2 | GO:0021902 | |
| GeneOntologyBiologicalProcess | regulation of forebrain neuron differentiation | 4.32e-04 | 6 | 112 | 2 | GO:2000977 | |
| GeneOntologyBiologicalProcess | lens morphogenesis in camera-type eye | 4.62e-04 | 28 | 112 | 3 | GO:0002089 | |
| GeneOntologyBiologicalProcess | spinal cord development | 4.82e-04 | 119 | 112 | 5 | GO:0021510 | |
| GeneOntologyBiologicalProcess | miRNA metabolic process | 4.82e-04 | 119 | 112 | 5 | GO:0010586 | |
| GeneOntologyBiologicalProcess | regulation of neuroblast proliferation | 4.85e-04 | 67 | 112 | 4 | GO:1902692 | |
| GeneOntologyBiologicalProcess | regulation of neuron differentiation | 4.89e-04 | 255 | 112 | 7 | GO:0045664 | |
| GeneOntologyBiologicalProcess | embryonic morphogenesis | ALX3 SOX9 GATA2 DVL3 GATA6 KLF4 AXIN1 ZIC3 CITED2 GLI3 SOD1 PROX1 | 4.98e-04 | 713 | 112 | 12 | GO:0048598 |
| GeneOntologyBiologicalProcess | cellular response to transforming growth factor beta stimulus | 4.99e-04 | 336 | 112 | 8 | GO:0071560 | |
| GeneOntologyBiologicalProcess | organ growth | 5.01e-04 | 256 | 112 | 7 | GO:0035265 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | CACNA1A USP9X CD2AP DVL3 NTNG1 GAS7 POU4F1 BCL2 NKX2-1 GLI3 AUTS2 ULK1 TBR1 | 5.02e-04 | 819 | 112 | 13 | GO:0120039 |
| GeneOntologyBiologicalProcess | branching involved in ureteric bud morphogenesis | 5.13e-04 | 68 | 112 | 4 | GO:0001658 | |
| GeneOntologyCellularComponent | chromatin | SOX1 ALX3 SOX9 SOX10 DVL3 GATA6 IRF7 POU4F1 NKX2-6 KLF4 ZNF446 MEOX1 CITED2 NCOR2 SOX21 NFATC2 UBR5 NKX2-1 ANKRD17 TNKS1BP1 TBR1 SAP130 PROX1 | 3.57e-06 | 1480 | 113 | 23 | GO:0000785 |
| GeneOntologyCellularComponent | CKM complex | 2.87e-04 | 5 | 113 | 2 | GO:1990508 | |
| GeneOntologyCellularComponent | transcription regulator complex | SOX9 GATA2 GATA6 POU4F1 KLF4 NCOR2 DACH2 NFATC2 NKX2-1 GLI3 MED22 | 3.88e-04 | 596 | 113 | 11 | GO:0005667 |
| GeneOntologyCellularComponent | manchette | 4.57e-04 | 28 | 113 | 3 | GO:0002177 | |
| Domain | HMG_box_dom | 1.21e-07 | 65 | 112 | 7 | IPR009071 | |
| Domain | AUTS2 | 2.10e-07 | 3 | 112 | 3 | IPR023246 | |
| Domain | HMG_box | 7.42e-07 | 53 | 112 | 6 | PF00505 | |
| Domain | HMG | 8.30e-07 | 54 | 112 | 6 | SM00398 | |
| Domain | HMG_BOX_2 | 1.77e-05 | 54 | 112 | 5 | PS50118 | |
| Domain | - | 1.94e-05 | 55 | 112 | 5 | 1.10.30.10 | |
| Domain | SH3_9 | 1.06e-04 | 78 | 112 | 5 | PF14604 | |
| Domain | Sox_N | 1.07e-04 | 3 | 112 | 2 | IPR022151 | |
| Domain | Sox_N | 1.07e-04 | 3 | 112 | 2 | PF12444 | |
| Domain | SOXp | 3.52e-04 | 5 | 112 | 2 | PF12336 | |
| Domain | SOX_fam | 3.52e-04 | 5 | 112 | 2 | IPR022097 | |
| Domain | DIX | 7.34e-04 | 7 | 112 | 2 | PF00778 | |
| Domain | DIX | 7.34e-04 | 7 | 112 | 2 | IPR001158 | |
| Domain | DIX | 7.34e-04 | 7 | 112 | 2 | PS50841 | |
| Domain | DAX | 7.34e-04 | 7 | 112 | 2 | SM00021 | |
| Pathway | WP_MAP3K1_ROLE_IN_PROMOTING_AND_BLOCKING_GONADAL_DETERMINATION | 1.35e-04 | 17 | 85 | 3 | M39907 | |
| Pathway | WP_CELL_LINEAGE_MAP_FOR_NEURONAL_DIFFERENTIATION | 1.44e-04 | 132 | 85 | 6 | M48110 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION | 1.50e-04 | 84 | 85 | 5 | M1008 | |
| Pathway | PID_BETA_CATENIN_DEG_PATHWAY | 1.62e-04 | 18 | 85 | 3 | M31 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION | CDK8 SOX9 ELOA2 ARID3A USP9X GATA2 POU4F1 KLF4 ZNF446 AXIN1 CITED2 KMT2C NCOR2 NFATC2 GLI3 ZNF589 AUTS2 TNKS1BP1 MMP13 MED13 | 1.71e-04 | 1387 | 85 | 20 | M734 |
| Pathway | WP_WNT_SIGNALING_WP363 | 2.48e-04 | 51 | 85 | 4 | M39721 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | SOX1 CDK8 ALX3 SOX9 SOX10 RPS6KA2 PAK5 GATA2 GATA6 BCL2 KLF4 ZIC3 KMT2C NCOR2 ZFP36L2 MED22 SCN5A CLTB TNKS1BP1 MED13 | 2.62e-04 | 1432 | 85 | 20 | M509 |
| Pathway | WP_MESODERMAL_COMMITMENT_PATHWAY | 3.20e-04 | 153 | 85 | 6 | M39546 | |
| Pubmed | SOX9 SOX10 ZNF219 ARID3A GATA2 GATA6 DIDO1 KLF4 SF1 MEOX1 CITED2 KMT2C ST6GAL2 IBTK SOX21 NFATC2 NKX2-1 GLI3 HMGXB3 PROX1 | 2.25e-13 | 709 | 115 | 20 | 22988430 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | SOX1 ALX3 SOX9 SOX10 GATA2 GATA6 IRF7 POU4F1 NKX2-6 KLF4 MEOX1 USF3 SOX21 DACH2 NFATC2 ZFP36L2 NKX2-1 GLI3 TBR1 PROX1 | 1.98e-11 | 908 | 115 | 20 | 19274049 |
| Pubmed | SOX9 SOX10 ARID3A ATN1 PITRM1 TRIP6 USP9X FBRS GATA2 FBRSL1 GATA6 DIDO1 PROSER1 KLF4 ZIC3 KMT2C NCOR2 SMG7 GLI3 AUTS2 ANKRD17 TBR1 SAP130 | 2.65e-10 | 1429 | 115 | 23 | 35140242 | |
| Pubmed | SOX1 ZNF219 ARID3A TRIP6 GATA2 GATA6 DIDO1 KLF4 ZNF446 SF1 CITED2 IBTK SOX21 ZFP36L2 NKX2-1 GLI3 HMGXB3 | 1.48e-09 | 808 | 115 | 17 | 20412781 | |
| Pubmed | 1.60e-08 | 191 | 115 | 9 | 24146773 | ||
| Pubmed | Impact of cytosine methylation on DNA binding specificities of human transcription factors. | ALX3 SOX9 SOX10 GATA2 GATA6 IRF7 POU4F1 KLF4 ZIC3 MEOX1 NFATC2 GLI3 PROX1 | 3.32e-08 | 544 | 115 | 13 | 28473536 |
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | ALX3 SOX9 ZNF219 ELOA2 GATA2 GATA6 IRF7 POU4F1 ZNF446 MEOX1 NCOR2 DACH2 NKX2-1 GLI3 HMGXB3 PROX1 | 3.41e-08 | 877 | 115 | 16 | 20211142 |
| Pubmed | 4.41e-08 | 152 | 115 | 8 | 38360978 | ||
| Pubmed | RIM-BP3 is a manchette-associated protein essential for spermiogenesis. | 1.41e-07 | 4 | 115 | 3 | 19091768 | |
| Pubmed | CDK8 ZNF219 ATN1 TRIP6 FBRS FBRSL1 GAS7 NCOR2 SMG7 UBR5 GLI3 ZNF589 CPEB4 SCN5A ANKRD17 SAP130 PROX1 | 1.63e-07 | 1116 | 115 | 17 | 31753913 | |
| Pubmed | PITRM1 FBRSL1 DIDO1 KMT2C ST6GAL2 IBTK SMG7 AUTS2 ANKRD17 HMGXB3 TNKS1BP1 MED13 | 2.02e-07 | 529 | 115 | 12 | 14621295 | |
| Pubmed | 2.61e-07 | 17 | 115 | 4 | 23444355 | ||
| Pubmed | Spatio-temporal expression of Sox genes in murine palatogenesis. | 2.61e-07 | 17 | 115 | 4 | 27241892 | |
| Pubmed | 3.35e-07 | 18 | 115 | 4 | 26864488 | ||
| Pubmed | Structure and evolution of RIM-BP genes: identification of a novel family member. | 3.50e-07 | 5 | 115 | 3 | 17855024 | |
| Pubmed | Testicular differentiation occurs in absence of R-spondin1 and Sox9 in mouse sex reversals. | 6.50e-07 | 21 | 115 | 4 | 23300469 | |
| Pubmed | Deficiency of splicing factor 1 suppresses the occurrence of testicular germ cell tumors. | 6.99e-07 | 6 | 115 | 3 | 20736371 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ARID3A RPS6KA2 FBRS GATA2 FBRSL1 PAPLN KLF4 KMT2C NCOR2 ZFP36L2 SCN5A HMGXB3 TNKS1BP1 DTX2 ULK1 MED13 | 7.61e-07 | 1105 | 115 | 16 | 35748872 |
| Pubmed | 7.92e-07 | 22 | 115 | 4 | 15162501 | ||
| Pubmed | Ets1 is required for proper migration and differentiation of the cardiac neural crest. | 7.92e-07 | 22 | 115 | 4 | 20356956 | |
| Pubmed | 1.22e-06 | 7 | 115 | 3 | 24970044 | ||
| Pubmed | 1.84e-06 | 335 | 115 | 9 | 15741177 | ||
| Pubmed | Mutations in MAP3K1 tilt the balance from SOX9/FGF9 to WNT/β-catenin signaling. | 1.95e-06 | 8 | 115 | 3 | 24135036 | |
| Pubmed | 1.95e-06 | 8 | 115 | 3 | 24198279 | ||
| Pubmed | 2.91e-06 | 30 | 115 | 4 | 28560839 | ||
| Pubmed | 2.91e-06 | 30 | 115 | 4 | 16368932 | ||
| Pubmed | MAP3K1 functionally interacts with Axin1 in the canonical Wnt signalling pathway. | 2.92e-06 | 9 | 115 | 3 | 20128690 | |
| Pubmed | CD2AP FBRS GATA6 PTPN23 DIDO1 SEC31A CUBN KLF4 KMT2C ANKRD17 HMGXB3 BOD1L1 DTX2 TNS1 SOD1 | 3.02e-06 | 1084 | 115 | 15 | 11544199 | |
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | 3.03e-06 | 457 | 115 | 10 | 32344865 | |
| Pubmed | 3.33e-06 | 31 | 115 | 4 | 19723505 | ||
| Pubmed | CACNA1A ZNF219 USP9X RPS6KA2 PAK5 IQSEC2 DIDO1 SEC31A NCOR2 UBR5 ANKRD17 TNS1 FERMT3 PROX1 | 3.78e-06 | 963 | 115 | 14 | 28671696 | |
| Pubmed | 4.16e-06 | 10 | 115 | 3 | 10037800 | ||
| Pubmed | Sox10 promotes the survival of cochlear progenitors during the establishment of the organ of Corti. | 4.16e-06 | 10 | 115 | 3 | 19748502 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | TRIP6 USP9X FBRS FBRSL1 RIMBP3 TBC1D8 NCOR2 SMG7 UBR5 TNKS1BP1 CDCA4 | 4.28e-06 | 588 | 115 | 11 | 38580884 |
| Pubmed | 4.31e-06 | 33 | 115 | 4 | 25179941 | ||
| Pubmed | 4.87e-06 | 34 | 115 | 4 | 12086465 | ||
| Pubmed | The cortical hem lacks stem cell potential despite expressing SOX9 and HOPX. | 5.70e-06 | 11 | 115 | 3 | 36067402 | |
| Pubmed | 6.16e-06 | 36 | 115 | 4 | 18094027 | ||
| Pubmed | 6.89e-06 | 37 | 115 | 4 | 22001906 | ||
| Pubmed | 7.14e-06 | 396 | 115 | 9 | 26687479 | ||
| Pubmed | 7.58e-06 | 12 | 115 | 3 | 11071752 | ||
| Pubmed | An AUTS2-Polycomb complex activates gene expression in the CNS. | 7.68e-06 | 38 | 115 | 4 | 25519132 | |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | TRIP6 USP9X IQSEC2 FBRS DVL3 FBRSL1 SIK1 SEC31A MAP3K1 AXIN1 SMG7 UBR5 ZFP36L2 TNKS1BP1 | 8.85e-06 | 1038 | 115 | 14 | 26673895 |
| Pubmed | Seven new members of the Sox gene family expressed during mouse development. | 9.83e-06 | 13 | 115 | 3 | 8441686 | |
| Pubmed | 9.83e-06 | 13 | 115 | 3 | 38159590 | ||
| Pubmed | CDK8 is a positive regulator of transcriptional elongation within the serum response network. | 9.83e-06 | 13 | 115 | 3 | 20098423 | |
| Pubmed | VE-Cadherin Is Required for Lymphatic Valve Formation and Maintenance. | 9.83e-06 | 13 | 115 | 3 | 31461654 | |
| Pubmed | 9.83e-06 | 13 | 115 | 3 | 27570068 | ||
| Pubmed | Post-transcriptional regulation in cranial neural crest cells expands developmental potential. | 9.83e-06 | 13 | 115 | 3 | 36724256 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 35848993 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 33985544 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 10415149 | ||
| Pubmed | Characterization of the interactions of human ZIC3 mutants with GLI3. | 1.08e-05 | 2 | 115 | 2 | 17764085 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 37972693 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 25629959 | ||
| Pubmed | Expression of SOX9 and SOX10 in central neuroepithelial tumor. | 1.08e-05 | 2 | 115 | 2 | 16791471 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 32778883 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 24603652 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 16790527 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 34167360 | ||
| Pubmed | Disruption of GLI3-ZIC3 interaction in the cadmium-induced omphalocele chick model. | 1.08e-05 | 2 | 115 | 2 | 21069353 | |
| Pubmed | Co-expression of SOX9 and SOX10 during melanocytic differentiation in vitro. | 1.08e-05 | 2 | 115 | 2 | 15896776 | |
| Pubmed | ALS-linked mutant SOD1 damages mitochondria by promoting conformational changes in Bcl-2. | 1.08e-05 | 2 | 115 | 2 | 20460269 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 36224534 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 15233914 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 17196582 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 10575011 | ||
| Pubmed | Aberrant GATA2 epigenetic dysregulation induces a GATA2/GATA6 switch in human gastric cancer. | 1.08e-05 | 2 | 115 | 2 | 29106391 | |
| Pubmed | CITED2 and NCOR2 in anti-oestrogen resistance and progression of breast cancer. | 1.08e-05 | 2 | 115 | 2 | 19904269 | |
| Pubmed | Dentate gyrus development requires a cortical hem-derived astrocytic scaffold. | 1.25e-05 | 14 | 115 | 3 | 33393905 | |
| Pubmed | Integrative characterization of germ cell-specific genes from mouse spermatocyte UniGene library. | 1.25e-05 | 14 | 115 | 3 | 17662146 | |
| Pubmed | Developmental diversification of cortical inhibitory interneurons. | 1.34e-05 | 91 | 115 | 5 | 29513653 | |
| Pubmed | TRIP6 USP9X CD2AP PTPN23 DIDO1 KMT2C SMG7 TNKS1BP1 BOD1L1 SAP130 | 1.50e-05 | 549 | 115 | 10 | 38280479 | |
| Pubmed | 1.56e-05 | 15 | 115 | 3 | 15893981 | ||
| Pubmed | Loss of Axin2 Causes Ocular Defects During Mouse Eye Development. | 1.56e-05 | 15 | 115 | 3 | 27701636 | |
| Pubmed | 1.91e-05 | 16 | 115 | 3 | 24257626 | ||
| Pubmed | 1.91e-05 | 16 | 115 | 3 | 15384171 | ||
| Pubmed | 1.91e-05 | 16 | 115 | 3 | 24125957 | ||
| Pubmed | A conserved molecular logic for neurogenesis to gliogenesis switch in the cerebral cortex. | 1.91e-05 | 16 | 115 | 3 | 38713624 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | 2.30e-05 | 351 | 115 | 8 | 38297188 | |
| Pubmed | MicroRNA-140 plays dual roles in both cartilage development and homeostasis. | 2.32e-05 | 17 | 115 | 3 | 20466812 | |
| Pubmed | 2.32e-05 | 17 | 115 | 3 | 28778798 | ||
| Pubmed | 2.32e-05 | 17 | 115 | 3 | 17274974 | ||
| Pubmed | NRF1 association with AUTS2-Polycomb mediates specific gene activation in the brain. | 2.32e-05 | 17 | 115 | 3 | 34637754 | |
| Pubmed | 2.32e-05 | 17 | 115 | 3 | 25501893 | ||
| Pubmed | 2.32e-05 | 17 | 115 | 3 | 18330926 | ||
| Pubmed | 2.32e-05 | 50 | 115 | 4 | 37974198 | ||
| Pubmed | NFIX regulates neural progenitor cell differentiation during hippocampal morphogenesis. | 2.77e-05 | 18 | 115 | 3 | 23042739 | |
| Pubmed | 2.77e-05 | 18 | 115 | 3 | 27654891 | ||
| Pubmed | 2.77e-05 | 18 | 115 | 3 | 14645126 | ||
| Pubmed | 2.77e-05 | 18 | 115 | 3 | 27352137 | ||
| Pubmed | 2.85e-05 | 263 | 115 | 7 | 20932939 | ||
| Pubmed | A BMP-controlled metabolic/epigenetic signaling cascade directs midfacial morphogenesis. | 2.93e-05 | 53 | 115 | 4 | 38466355 | |
| Pubmed | Coeliac disease-associated risk variants in TNFAIP3 and REL implicate altered NF-kappaB signalling. | 3.00e-05 | 265 | 115 | 7 | 19240061 | |
| Pubmed | 3.22e-05 | 268 | 115 | 7 | 33640491 | ||
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 18437159 | ||
| Pubmed | Rare genetic variants in GATA transcription factors in patients with hypertrophic cardiomyopathy. | 3.24e-05 | 3 | 115 | 2 | 28381408 | |
| Pubmed | Preaxial polydactyly caused by Gli3 haploinsufficiency is rescued by Zic3 loss of function in mice. | 3.24e-05 | 3 | 115 | 2 | 22234993 | |
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 26467042 | ||
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 21126317 | ||
| Interaction | NFIC interactions | SOX9 SOX10 ARID3A FBRS GATA2 FBRSL1 NCOR2 NKX2-1 DTX2 TBR1 SAP130 | 2.78e-08 | 210 | 113 | 11 | int:NFIC |
| Interaction | BCL9 interactions | 2.81e-08 | 86 | 113 | 8 | int:BCL9 | |
| Interaction | NCOA3 interactions | SOX9 SOX10 ZNF219 GATA2 KLF4 NCOR2 SMG7 NKX2-1 DTX2 TBR1 MN1 | 5.39e-08 | 224 | 113 | 11 | int:NCOA3 |
| Interaction | EYA4 interactions | ATN1 TRIP6 FBRS GATA2 DVL3 FBRSL1 PROSER1 SF1 NCOR2 AUTS2 DTX2 | 1.23e-07 | 243 | 113 | 11 | int:EYA4 |
| Interaction | TLE3 interactions | SOX9 ATN1 FBRS GATA2 FBRSL1 PROSER1 NCOR2 SMG7 UBR5 AUTS2 TNKS1BP1 TBR1 SAP130 | 1.93e-07 | 376 | 113 | 13 | int:TLE3 |
| Interaction | PIN1 interactions | ATN1 TRIP6 DIDO1 SIK1 BCL2 ZNF446 SF1 ZNF783 AXIN1 MEOX1 NCOR2 NFATC2 SOD1 | 2.38e-07 | 383 | 113 | 13 | int:PIN1 |
| Interaction | TBXT interactions | 2.92e-07 | 116 | 113 | 8 | int:TBXT | |
| Interaction | FANCD2OS interactions | 3.04e-07 | 26 | 113 | 5 | int:FANCD2OS | |
| Interaction | PAX9 interactions | 7.00e-07 | 130 | 113 | 8 | int:PAX9 | |
| Interaction | CREBBP interactions | CDK8 SOX9 RPS6KA2 GATA2 IRF7 KLF4 CITED2 PPP1R8 NCOR2 SMG7 NFATC2 NKX2-1 GLI3 DYRK1B PROX1 | 1.29e-06 | 599 | 113 | 15 | int:CREBBP |
| Interaction | NFIB interactions | 1.37e-06 | 142 | 113 | 8 | int:NFIB | |
| Interaction | ZNF609 interactions | 1.69e-06 | 146 | 113 | 8 | int:ZNF609 | |
| Interaction | CTBP1 interactions | ZNF219 FBRS DVL3 FBRSL1 SEC31A KLF4 SF1 NCOR2 NFATC2 NKX2-1 DYRK1B DTX2 | 3.01e-06 | 406 | 113 | 12 | int:CTBP1 |
| Interaction | KDM6A interactions | 3.67e-06 | 162 | 113 | 8 | int:KDM6A | |
| Interaction | TNRC6A interactions | 4.03e-06 | 280 | 113 | 10 | int:TNRC6A | |
| Interaction | CEP85 interactions | 5.02e-06 | 169 | 113 | 8 | int:CEP85 | |
| Interaction | KMT2D interactions | 5.02e-06 | 169 | 113 | 8 | int:KMT2D | |
| Interaction | EGR2 interactions | 5.48e-06 | 171 | 113 | 8 | int:EGR2 | |
| Interaction | TLX1 interactions | 6.49e-06 | 175 | 113 | 8 | int:TLX1 | |
| Interaction | BCOR interactions | 7.84e-06 | 302 | 113 | 10 | int:BCOR | |
| Interaction | SP7 interactions | ARID3A ATN1 PITRM1 FBRS FBRSL1 PROSER1 KMT2C NCOR2 TBR1 SAP130 | 8.30e-06 | 304 | 113 | 10 | int:SP7 |
| Interaction | PRR12 interactions | 1.01e-05 | 88 | 113 | 6 | int:PRR12 | |
| Interaction | HIVEP1 interactions | 1.01e-05 | 186 | 113 | 8 | int:HIVEP1 | |
| Interaction | KMT2C interactions | 1.06e-05 | 134 | 113 | 7 | int:KMT2C | |
| Interaction | SMAD2 interactions | CDK8 SOX9 USP9X IRF7 AXIN1 CITED2 KMT2C UBR5 GLI3 MED22 SOD1 | 1.09e-05 | 385 | 113 | 11 | int:SMAD2 |
| Interaction | NFIA interactions | 1.10e-05 | 188 | 113 | 8 | int:NFIA | |
| Interaction | HNF1B interactions | 1.18e-05 | 190 | 113 | 8 | int:HNF1B | |
| Interaction | ZNF608 interactions | 1.39e-05 | 93 | 113 | 6 | int:ZNF608 | |
| Interaction | ARID4B interactions | 1.66e-05 | 199 | 113 | 8 | int:ARID4B | |
| Interaction | NCOA6 interactions | 1.76e-05 | 145 | 113 | 7 | int:NCOA6 | |
| Interaction | RING1 interactions | 1.78e-05 | 201 | 113 | 8 | int:RING1 | |
| Interaction | HIPK2 interactions | 1.88e-05 | 98 | 113 | 6 | int:HIPK2 | |
| Interaction | NUP35 interactions | ATN1 TRIP6 FBRS KMT2C NCOR2 SMG7 NKX2-1 AUTS2 ANKRD17 DTX2 SAP130 | 2.67e-05 | 424 | 113 | 11 | int:NUP35 |
| Interaction | MED19 interactions | 2.94e-05 | 106 | 113 | 6 | int:MED19 | |
| Interaction | TNRC6B interactions | 3.04e-05 | 282 | 113 | 9 | int:TNRC6B | |
| Interaction | KDM2B interactions | 3.46e-05 | 161 | 113 | 7 | int:KDM2B | |
| Interaction | ERG interactions | 3.74e-05 | 223 | 113 | 8 | int:ERG | |
| Interaction | PAX6 interactions | 4.08e-05 | 366 | 113 | 10 | int:PAX6 | |
| Interaction | TBR1 interactions | 4.22e-05 | 113 | 113 | 6 | int:TBR1 | |
| Interaction | NFIX interactions | 4.25e-05 | 227 | 113 | 8 | int:NFIX | |
| Interaction | DCAF7 interactions | SOX10 FBRS GATA2 FBRSL1 SIK1 SEC31A MAP3K1 NFATC2 DYRK1B AUTS2 | 4.27e-05 | 368 | 113 | 10 | int:DCAF7 |
| Interaction | TOP3B interactions | ARID3A RPS6KA2 FBRS GATA2 FBRSL1 PAPLN KLF4 KMT2C NCOR2 IBTK SAFB SMG7 ZFP36L2 CPEB4 SCN5A ANKRD17 HMGXB3 TNKS1BP1 DTX2 ULK1 MED13 | 6.09e-05 | 1470 | 113 | 21 | int:TOP3B |
| Interaction | PAX7 interactions | 7.10e-05 | 124 | 113 | 6 | int:PAX7 | |
| Interaction | CRX interactions | 9.34e-05 | 254 | 113 | 8 | int:CRX | |
| Interaction | RCOR1 interactions | CD2AP FBRS GATA2 DVL3 KLF4 NCOR2 NFATC2 UBR5 NKX2-1 ANKRD17 TNKS1BP1 | 1.05e-04 | 494 | 113 | 11 | int:RCOR1 |
| Interaction | POU5F1 interactions | SOX10 ZNF219 USP9X CUBN KLF4 ZIC3 NCOR2 IBTK SOX21 UBR5 ANKRD17 SAP130 | 1.08e-04 | 584 | 113 | 12 | int:POU5F1 |
| Interaction | IRF4 interactions | 1.16e-04 | 85 | 113 | 5 | int:IRF4 | |
| Interaction | PRRC2B interactions | 1.25e-04 | 265 | 113 | 8 | int:PRRC2B | |
| Interaction | GSC interactions | 1.30e-04 | 87 | 113 | 5 | int:GSC | |
| Interaction | GATA2 interactions | 1.32e-04 | 199 | 113 | 7 | int:GATA2 | |
| Interaction | CAPN13 interactions | 1.56e-04 | 19 | 113 | 3 | int:CAPN13 | |
| Interaction | SOX10 interactions | 1.69e-04 | 92 | 113 | 5 | int:SOX10 | |
| Interaction | FOXI1 interactions | 1.69e-04 | 92 | 113 | 5 | int:FOXI1 | |
| Interaction | PCGF1 interactions | 1.73e-04 | 208 | 113 | 7 | int:PCGF1 | |
| Interaction | DPF1 interactions | 1.97e-04 | 95 | 113 | 5 | int:DPF1 | |
| Interaction | TLE1 interactions | 2.00e-04 | 213 | 113 | 7 | int:TLE1 | |
| Interaction | TP53BP1 interactions | CDK8 ALX3 ARID3A PPP1R8 SAFB NFATC2 UBR5 MED22 USPL1 SAP130 MED13 | 2.04e-04 | 533 | 113 | 11 | int:TP53BP1 |
| Interaction | KDM1A interactions | USP9X TEDC2 CD2AP FBRS GATA2 DVL3 NCOR2 SMG7 NFATC2 UBR5 NKX2-1 ANKRD17 TNKS1BP1 PROX1 CDCA4 | 2.45e-04 | 941 | 113 | 15 | int:KDM1A |
| Interaction | ODF2 interactions | 2.67e-04 | 158 | 113 | 6 | int:ODF2 | |
| Interaction | EP300 interactions | SOX9 SOX10 TENT4A USP9X GATA2 GATA6 IRF7 SEC31A KLF4 SF1 CITED2 NCOR2 SAFB NFATC2 DYRK1B AUTS2 TBR1 MN1 PROX1 | 2.80e-04 | 1401 | 113 | 19 | int:EP300 |
| Interaction | ZNF503 interactions | 2.94e-04 | 57 | 113 | 4 | int:ZNF503 | |
| Interaction | KLF3 interactions | 3.03e-04 | 228 | 113 | 7 | int:KLF3 | |
| Interaction | YTHDF1 interactions | 3.04e-04 | 302 | 113 | 8 | int:YTHDF1 | |
| Interaction | NANOG interactions | ZNF219 ARID3A USP9X DIDO1 ZIC3 KMT2C NCOR2 IBTK SOX21 SAP130 | 3.78e-04 | 481 | 113 | 10 | int:NANOG |
| Interaction | PAX8 interactions | 4.05e-04 | 111 | 113 | 5 | int:PAX8 | |
| Interaction | PRR32 interactions | 4.61e-04 | 6 | 113 | 2 | int:PRR32 | |
| Interaction | LDB1 interactions | 4.77e-04 | 115 | 113 | 5 | int:LDB1 | |
| Interaction | RUNX1 interactions | 4.85e-04 | 324 | 113 | 8 | int:RUNX1 | |
| Interaction | ARID1B interactions | 4.90e-04 | 177 | 113 | 6 | int:ARID1B | |
| Interaction | ZNF750 interactions | 5.08e-04 | 28 | 113 | 3 | int:ZNF750 | |
| Interaction | AURKA interactions | CDK8 PITRM1 TRIP6 USP9X PAK5 PTPN23 KLF4 CEP128 NCOR2 SAFB UBR5 TNKS1BP1 | 5.35e-04 | 696 | 113 | 12 | int:AURKA |
| Interaction | ALG13 interactions | 5.84e-04 | 183 | 113 | 6 | int:ALG13 | |
| Interaction | WWTR1 interactions | 6.23e-04 | 422 | 113 | 9 | int:WWTR1 | |
| Interaction | FRS3 interactions | 6.24e-04 | 122 | 113 | 5 | int:FRS3 | |
| Interaction | SSPOP interactions | 6.43e-04 | 7 | 113 | 2 | int:SSPOP | |
| Interaction | TAF1 interactions | 6.63e-04 | 260 | 113 | 7 | int:TAF1 | |
| Interaction | FAM193A interactions | 6.82e-04 | 71 | 113 | 4 | int:FAM193A | |
| Interaction | PROSER1 interactions | 6.88e-04 | 31 | 113 | 3 | int:PROSER1 | |
| Interaction | DGCR6L interactions | 6.88e-04 | 31 | 113 | 3 | int:DGCR6L | |
| Interaction | CEP44 interactions | 6.92e-04 | 189 | 113 | 6 | int:CEP44 | |
| Interaction | MBP interactions | 7.22e-04 | 126 | 113 | 5 | int:MBP | |
| Interaction | NCOR2 interactions | 7.25e-04 | 264 | 113 | 7 | int:NCOR2 | |
| Interaction | PML interactions | ARID3A CD2AP PAK5 GATA2 DVL3 IRF7 BCL2 SF1 AXIN1 NCOR2 SAFB UBR5 TNKS1BP1 SAP130 | 7.27e-04 | 933 | 113 | 14 | int:PML |
| Interaction | SMARCA2 interactions | 7.46e-04 | 346 | 113 | 8 | int:SMARCA2 | |
| GeneFamily | SRY-boxes | 8.56e-07 | 19 | 72 | 4 | 757 | |
| GeneFamily | Cyclins|Mediator complex | 3.03e-04 | 33 | 72 | 3 | 1061 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 1.59e-03 | 15 | 72 | 2 | 82 | |
| Coexpression | BENPORATH_SUZ12_TARGETS | SOX1 ALX3 CACNA1A SOX9 SOX10 GATA2 GATA6 GAS7 POU4F1 BCL2 GPR88 KLF4 ADCY8 RIMBP3 SOX21 DACH2 NKX2-1 RIMBP3C TBR1 FUT4 RIMBP3B | 3.61e-09 | 1035 | 114 | 21 | M9898 |
| Coexpression | BENPORATH_PRC2_TARGETS | ALX3 GATA2 GATA6 POU4F1 BCL2 GPR88 KLF4 ADCY8 RIMBP3 DACH2 NKX2-1 RIMBP3C TBR1 FUT4 RIMBP3B | 1.52e-07 | 650 | 114 | 15 | M8448 |
| Coexpression | BENPORATH_ES_WITH_H3K27ME3 | ALX3 IL10RA CACNA1A SOX9 RPS6KA2 GATA2 GATA6 POU4F1 BCL2 GPR88 KLF4 ADCY8 RIMBP3 DACH2 NKX2-1 RIMBP3C TBR1 FUT4 RIMBP3B | 3.33e-07 | 1115 | 114 | 19 | M10371 |
| Coexpression | BENPORATH_EED_TARGETS | SOX1 ALX3 GATA2 GATA6 POU4F1 BCL2 GPR88 KLF4 ADCY8 RIMBP3 SOX21 DACH2 NKX2-1 AUTS2 RIMBP3C TBR1 FUT4 RIMBP3B | 7.31e-07 | 1059 | 114 | 18 | M7617 |
| Coexpression | GSE3982_DC_VS_NKCELL_DN | 2.46e-06 | 197 | 114 | 8 | M5480 | |
| Coexpression | GSE13485_DAY3_VS_DAY21_YF17D_VACCINE_PBMC_UP | 2.23e-05 | 193 | 114 | 7 | M3303 | |
| Coexpression | GSE26343_WT_VS_NFAT5_KO_MACROPHAGE_DN | 2.80e-05 | 200 | 114 | 7 | M8647 | |
| Coexpression | ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP | 2.90e-05 | 452 | 114 | 10 | M18685 | |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_DN | ALX3 CACNA1A SOX9 GATA2 GPR135 GAS7 VWA7 MSRB2 SMG7 DYRK1B DTX2 TNS1 TNXA CDCA4 | 4.13e-05 | 909 | 114 | 14 | M41018 |
| Coexpression | MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3 | SOX1 SOX9 GATA2 GATA6 GPR88 KLF4 ZIC3 SOX21 NFATC2 ZFP36L2 GLI3 SCN5A TBR1 FUT4 PROX1 | 6.55e-05 | 1074 | 114 | 15 | M1941 |
| ToppCell | normal_Lymph_Node-Myeloid_cells-pDCs|Myeloid_cells / Location, Cell class and cell subclass | 3.53e-07 | 174 | 115 | 7 | 2274648b80dd74f3c948a779bba3391095964c34 | |
| ToppCell | facs-Skin-nan-18m-Epithelial-outer_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.61e-07 | 195 | 115 | 7 | ba7cb80deb872c9184769f0dd57855c3c6a432bf | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-pDCs|normal_Lymph_Node / Location, Cell class and cell subclass | 6.50e-06 | 176 | 115 | 6 | 476794ef75ce5ab732d78cfeb4944e2f841e3e92 | |
| ToppCell | COPD-Myeloid-pDC|COPD / Disease state, Lineage and Cell class | 6.72e-06 | 177 | 115 | 6 | 415aa023195a7f961c09529f65cdcc7bb90eaf5d | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1_FGFR3_MT1G|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.94e-06 | 178 | 115 | 6 | 4813d6509738f088c12ebf395b70d496af04649a | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 8.13e-06 | 183 | 115 | 6 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | CF-Myeloid-cDC|Myeloid / Disease state, Lineage and Cell class | 1.13e-05 | 194 | 115 | 6 | 3feb8a0ba3368673c53e9cbd4980e73d18697718 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-05 | 195 | 115 | 6 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-05 | 195 | 115 | 6 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | mLN-T_cell-Treg|T_cell / Region, Cell class and subclass | 1.24e-05 | 197 | 115 | 6 | 3779489d57ebda33277c79cba037f4c73128c8ba | |
| ToppCell | facs-Brain_Myeloid-Cortex_-18m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.24e-05 | 197 | 115 | 6 | e73ca8c8f42cbcc56eaa5fe3d69abd1ce7b7bbca | |
| ToppCell | facs-Brain_Myeloid-Cortex_|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.24e-05 | 197 | 115 | 6 | 81379fe6bd14a1ba26f4a159497262adcb600b18 | |
| ToppCell | facs-Brain_Myeloid-Cortex_-18m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.24e-05 | 197 | 115 | 6 | 271c75f491d03bd248c7ec037ef02e39456f3ac0 | |
| ToppCell | facs-Brain_Myeloid-Cortex_-18m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.24e-05 | 197 | 115 | 6 | 9db329c6fea532dd1afb624f4c29c92407f45568 | |
| ToppCell | facs-Brain_Myeloid-Cortex_-18m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.24e-05 | 197 | 115 | 6 | 173c0c8de4e69882a9f91189deeb4a651fefe551 | |
| ToppCell | Thalamus|World / BrainAtlas - Mouse McCarroll V32 | 1.28e-05 | 116 | 115 | 5 | 5ddfb2dd5459ff6d7ae38163a38eae64fda283b7 | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-early|World / Primary Cells by Cluster | 1.31e-05 | 199 | 115 | 6 | 549391e7a4285da1c0e366654530bcf1cd33fbae | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-early-40|World / Primary Cells by Cluster | 1.31e-05 | 199 | 115 | 6 | 23625d757173bdd35a51c7919ff4b588168d2553 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors|1_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.31e-05 | 199 | 115 | 6 | 358c4b3037f59378db8916a2fbe9ed4830cf1449 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Crispld2_Htr2c|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.87e-05 | 146 | 115 | 5 | 47368f981180ca6a8c81a50f7f9430f12456f609 | |
| ToppCell | Mild_COVID-19-Myeloid-TRAM2|Mild_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 4.99e-05 | 154 | 115 | 5 | ab648f6b29eb9e499e46cbdbaf3c5cf6b94d1f64 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs_st-18m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.53e-05 | 163 | 115 | 5 | a24db9d266a40f3bffe4f18d277bc269791b4560 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | 7.12e-05 | 166 | 115 | 5 | 32d2eaf8a5d03881bf74d680825af2d5110b082d | |
| ToppCell | droplet-Fat-SCAT-30m-Lymphocytic-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.12e-05 | 166 | 115 | 5 | 67370c49d7aedcb4eca802095f06b30f6bbf8919 | |
| ToppCell | frontal_cortex-Non-neuronal-endothelial_cell-Endo-Endo_Ctla2a|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.12e-05 | 166 | 115 | 5 | 27af6c906cff1d40d134f0386db7708869691121 | |
| ToppCell | droplet-Fat-SCAT-30m-Lymphocytic|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.12e-05 | 166 | 115 | 5 | 7f4e5976ede6478636aa567d6fc2b56ff7295fb8 | |
| ToppCell | droplet-Marrow-BM-1m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.53e-05 | 168 | 115 | 5 | 2e88d9cb7c80a4656fab290db8b45a5a0599d769 | |
| ToppCell | 368C-Lymphocytic-ILC|368C / Donor, Lineage, Cell class and subclass (all cells) | 8.19e-05 | 171 | 115 | 5 | 3b3143e4aa6520ee9c6b6f2482206ad3d8205d14 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.19e-05 | 171 | 115 | 5 | 5efd15300f865ebf651e0888265cbd717bc3b9d3 | |
| ToppCell | 368C-Lymphocytic-ILC-ILC-2|368C / Donor, Lineage, Cell class and subclass (all cells) | 8.19e-05 | 171 | 115 | 5 | fd01076574dcc82bfd4a1538812500543b16794f | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Chat_Htr1f|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.19e-05 | 171 | 115 | 5 | f9ae7964a3740f559431125c17c660549798cccc | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Ccr7+_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.38e-05 | 176 | 115 | 5 | 24b2e94ee5defcefb64a1f2447a2cc71b015b0fd | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-myeloid_dendritic_cell-Ccr7+_dendritic|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.63e-05 | 177 | 115 | 5 | f360f7099570d248531897b96e0de282e58f59e9 | |
| ToppCell | BAL-Severe-cDC_3|Severe / Compartment, Disease Groups and Clusters | 9.63e-05 | 177 | 115 | 5 | 939487a05311b66edfc3f44a7955fbf25266d6bf | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L6_LAMP5_C1QL2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.89e-05 | 178 | 115 | 5 | 39889db130216655a34796e7030ffeb372465500 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-04 | 179 | 115 | 5 | 58ae5a97fe2a14e1c6fdeb886397eb06fdaf0428 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.04e-04 | 180 | 115 | 5 | 280ff5c8f292be1b88120db5ff1788b750644856 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.04e-04 | 180 | 115 | 5 | fdbd7c22044d9328a1e06e2f9a4451529d1df767 | |
| ToppCell | droplet-Marrow-BM|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-04 | 181 | 115 | 5 | 4169a1527b9c8f5783b8cc44e3a3924f8ed9a5e2 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Endothelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-04 | 182 | 115 | 5 | e6a734fb29105093d4cbfc3d0619a825b66da034 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Endothelial-Endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-04 | 182 | 115 | 5 | ccc313ecc0bfd8e2c6bb83a565b427b2310485ec | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Endothelial-endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-04 | 182 | 115 | 5 | b9f758961fb4a586ae86fa0b25edb8ce4616d644 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Neuronal-neuron_precursor|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.16e-04 | 184 | 115 | 5 | 7712f2e1fae5cdde2d4e355b860dc8536b28e4f6 | |
| ToppCell | droplet-Marrow-BM-1m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-04 | 184 | 115 | 5 | 69348c9237e44f7752ac01f60e733ad41580fdb8 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L6_LAMP5_C1QL2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.19e-04 | 185 | 115 | 5 | 6e7fefdd65d30abaffb26b92b0d04e1630d262ad | |
| ToppCell | droplet-Heart-4Chambers-18m-Mesenchymal-fibroblast|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-04 | 186 | 115 | 5 | 35c88cc4eb388811fcac4323b549e5897fa8dc27 | |
| ToppCell | droplet-Heart-4Chambers-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-04 | 186 | 115 | 5 | d998c5b00083cf2a7cd5341a98b7374b4de73c63 | |
| ToppCell | P07-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_artery|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.28e-04 | 188 | 115 | 5 | 5bc1537e079c7435196c163bff5f639ea392a33a | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c06-NR4A2|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.28e-04 | 188 | 115 | 5 | 939790f133eac9c12d08db6ddb5f08f5107844e3 | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-04 | 189 | 115 | 5 | 8e583ec4df0f5b79ce5211cc99ecd8616d180bde | |
| ToppCell | facs-Skin-Skin_Anagen-18m-Epithelial-outer_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-04 | 189 | 115 | 5 | d00410010283dc6191ce9857d6c7952678fed588 | |
| ToppCell | droplet-Heart-4Chambers-21m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-04 | 189 | 115 | 5 | 2a5fda73d38bdc23cf47e5335ffd4e086e990245 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Endothelial|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-04 | 189 | 115 | 5 | 92319bef1f00d6048ba8f9f8b5c6dbb896686b74 | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-04 | 189 | 115 | 5 | fb2253b8463d08b3d28e952a31a23dea2c2d986b | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.41e-04 | 192 | 115 | 5 | 4022f208eb5db760abd0aac782a25e8ab63efc64 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.41e-04 | 192 | 115 | 5 | 9333aba0d04203ccccad78d82bf6359922f810a7 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Endothelial-Endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.44e-04 | 193 | 115 | 5 | e4b440d50ae7391b26924778be6d9d53e0692449 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Endothelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.44e-04 | 193 | 115 | 5 | e523dc5751f6fdcd4fc1a62b1eecd43f6ae79da9 | |
| ToppCell | facs-Marrow-B-cells-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.44e-04 | 193 | 115 | 5 | 24c34c6635eb7fc2878282803c421b64320e77d8 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Endothelial-endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.44e-04 | 193 | 115 | 5 | 1772f2ac217727de63c4a9303881b3a19a6bb0f0 | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.48e-04 | 194 | 115 | 5 | 7ee8ac172c2dee7df7dc4eb222e0985a0089bda8 | |
| ToppCell | facs-Heart-RA-18m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.48e-04 | 194 | 115 | 5 | bc945450b350f597c3ff910d3a14a533d90086a8 | |
| ToppCell | facs-Heart-RA-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.52e-04 | 195 | 115 | 5 | 690d6e15d7c863fc8f2d33b1f7bf86f019f415c9 | |
| ToppCell | droplet-Marrow-BM-1m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.52e-04 | 195 | 115 | 5 | 637b06ef3967b03f7165d102d316e8b7161a817d | |
| ToppCell | facs-Heart-RA-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.52e-04 | 195 | 115 | 5 | 5c05e2bcea3d5d7ebe6325f7187ccf83301053d8 | |
| ToppCell | frontal_cortex-Non-neuronal-endothelial_cell-Endo-Endo_Cytl1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.53e-04 | 104 | 115 | 4 | 5d9cd14e53a2f1060e528abf6c0694be9d72c356 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Activated_Gen_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 1.63e-04 | 198 | 115 | 5 | 3c3a5d2555f6af4aa33f9ea778808315d0e39d86 | |
| ToppCell | (00)_Basal-(1)_GFP|(00)_Basal / shred by cell type by condition | 1.67e-04 | 199 | 115 | 5 | 105b15157f35df3fdf857e306f11e4e8200e05d4 | |
| ToppCell | IPF-Myeloid-Macrophage|Myeloid / Disease state, Lineage and Cell class | 1.67e-04 | 199 | 115 | 5 | 3c2b362d5e824e1a04830e70352f8818de984174 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.67e-04 | 199 | 115 | 5 | f3cc3cda38f78d1d12d865df339d93c5fecf19f2 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.67e-04 | 199 | 115 | 5 | c3c73c9404a73133bfad1f9ced292f5e508ef767 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW09-Neuronal|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 1.71e-04 | 200 | 115 | 5 | e9eb348a66011d8aace4331f84690ae27cb0d061 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW23-Macroglial-Glia_progenitor_cell|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 1.71e-04 | 200 | 115 | 5 | 859f98f63797087e7df18be632de153009b6cab1 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW10-Stem_cells|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 1.71e-04 | 200 | 115 | 5 | 474e6ab48f199315f3cca86b81fdf54e0461b7b8 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-Macroglial-Astrocyte|3m / Sample Type, Dataset, Time_group, and Cell type. | 1.71e-04 | 200 | 115 | 5 | 98d7f577b31a603bf835bf9b4ea31999445cf0e5 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW10-Macroglial-Astrocyte|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 1.71e-04 | 200 | 115 | 5 | 98a994692440cb4f505b050276f0c8022c814a21 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW13-Mesenchymal-Mesoderm|GW13 / Sample Type, Dataset, Time_group, and Cell type. | 1.71e-04 | 200 | 115 | 5 | 0f4b8b0868bda406fe6bf01d1b722510fdfd0168 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW09-Neuronal-Cortical_neuron|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 1.71e-04 | 200 | 115 | 5 | 44bc4d6616fc8d0ad8498e56125939034e8cff01 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW09-Neuronal|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 1.71e-04 | 200 | 115 | 5 | 09fd3cb31bcc02444f1045f01fe39bce09359d35 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW09-Neuronal-Neurons|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 1.71e-04 | 200 | 115 | 5 | ddac952ad1d46021c2d17d816de9bc31730a0941 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26-Neuronal-Cortical_neuron|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 1.71e-04 | 200 | 115 | 5 | 5b3df61ff421846ef4cabf1bd5355534c8b95509 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW10-Macroglial|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 1.71e-04 | 200 | 115 | 5 | ef222dc4a205d670172dae74990bdb952ac92e5b | |
| ToppCell | COVID-19-COVID-19_Mild|COVID-19 / Disease, condition lineage and cell class | 1.71e-04 | 200 | 115 | 5 | 62c25042086f1afd1102e0720e933c2e476468fd | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-Macroglial|3m / Sample Type, Dataset, Time_group, and Cell type. | 1.71e-04 | 200 | 115 | 5 | 38b51f337e183011e3ff32997ec26d8a424c6b78 | |
| ToppCell | mLN-Dendritic_cell-pDC|Dendritic_cell / Region, Cell class and subclass | 1.71e-04 | 200 | 115 | 5 | 10ae1ac8a98346320a92e855aebb3a7109f0ab9b | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW10-Stem_cells-Stem_cells|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 1.71e-04 | 200 | 115 | 5 | 01a29651e9bb64ef7666c6a61ec396eeb88b2816 | |
| Drug | glycidol | ALX3 IL10RA SOX9 CDC42BPG ARID3A IQSEC2 BCL2 NKX2-6 VWA7 KLF4 SSPOP ADCY8 FUT4 | 5.05e-07 | 466 | 112 | 13 | ctd:C004312 |
| Drug | 5213008; Down 200; 18uM; MCF7; HT_HG-U133A_EA | 5.30e-07 | 195 | 112 | 9 | 898_DN | |
| Drug | Fluvastatin sodium salt [93957-55-2]; Up 200; 9.2uM; PC3; HT_HG-U133A | 5.30e-07 | 195 | 112 | 9 | 6691_UP | |
| Drug | Naftifine hydrochloride [65473-14-5]; Down 200; 12.4uM; HL60; HT_HG-U133A | 5.53e-07 | 196 | 112 | 9 | 2974_DN | |
| Drug | Kynurenine, 3-hydroxy (R,S) [2147-61-7]; Up 200; 17.8uM; MCF7; HT_HG-U133A | 5.77e-07 | 197 | 112 | 9 | 5276_UP | |
| Drug | (-)-Adenosine 3',5'-cyclic monophosphate [60-92-4]; Up 200; 12.2uM; PC3; HT_HG-U133A | 6.02e-07 | 198 | 112 | 9 | 5108_UP | |
| Drug | ST021200; Down 200; 10uM; MCF7; HT_HG-U133A | 6.02e-07 | 198 | 112 | 9 | 7554_DN | |
| Drug | Pentetic acid [67-43-6]; Down 200; 10.2uM; PC3; HT_HG-U133A | 6.02e-07 | 198 | 112 | 9 | 4669_DN | |
| Drug | Niclosamide [50-65-7]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 1.16e-06 | 158 | 112 | 8 | 4136_UP | |
| Drug | Metaproterenol sulfate, orciprenaline sulfate [5874-97-5]; Down 200; 7.6uM; HL60; HT_HG-U133A | 5.37e-06 | 194 | 112 | 8 | 2485_DN | |
| Drug | Trimeprazine tartrate [4330-99-8]; Up 200; 5.4uM; MCF7; HT_HG-U133A | 5.57e-06 | 195 | 112 | 8 | 3478_UP | |
| Drug | Carcinine [56897-53-1]; Up 200; 22uM; PC3; HT_HG-U133A | 5.79e-06 | 196 | 112 | 8 | 4225_UP | |
| Drug | Paclitaxel [33069-62-4]; Up 200; 4.6uM; MCF7; HT_HG-U133A | 5.79e-06 | 196 | 112 | 8 | 5320_UP | |
| Drug | Theobromine [83-67-0]; Up 200; 22.2uM; MCF7; HT_HG-U133A | 5.79e-06 | 196 | 112 | 8 | 4958_UP | |
| Drug | Josamycin [16846-24-5]; Down 200; 4.8uM; PC3; HT_HG-U133A | 6.01e-06 | 197 | 112 | 8 | 4631_DN | |
| Drug | Atracurium besylate [64228-81-5]; Up 200; 3.2uM; MCF7; HT_HG-U133A | 6.01e-06 | 197 | 112 | 8 | 1702_UP | |
| Drug | Nadide [53-84-9]; Up 200; 6uM; MCF7; HT_HG-U133A | 6.01e-06 | 197 | 112 | 8 | 6091_UP | |
| Drug | Racecadotril [81110-73-8]; Down 200; 10.4uM; MCF7; HT_HG-U133A | 6.23e-06 | 198 | 112 | 8 | 2774_DN | |
| Drug | Palmatine chloride [3486-67-7]; Down 200; 10.4uM; PC3; HT_HG-U133A | 6.71e-06 | 200 | 112 | 8 | 6612_DN | |
| Drug | forskolin; Up 200; 50uM; MCF7; HT_HG-U133A_EA | 1.28e-05 | 157 | 112 | 7 | 913_UP | |
| Drug | retinoic acid; Up 200; 1uM; MCF7; HT_HG-U133A | 2.88e-05 | 178 | 112 | 7 | 1636_UP | |
| Drug | Doxorubicin hydrochloride [25316-40-9]; Down 200; 6.8uM; MCF7; HT_HG-U133A | 3.56e-05 | 184 | 112 | 7 | 5671_DN | |
| Drug | Cloperastine hydrochloride [14984-68-0]; Up 200; 11uM; MCF7; HT_HG-U133A | 4.22e-05 | 189 | 112 | 7 | 3408_UP | |
| Drug | Perphenazine [58-39-9]; Up 200; 10uM; PC3; HT_HG-U133A | 4.37e-05 | 190 | 112 | 7 | 4637_UP | |
| Drug | 15d-PGJ2; Down 200; 10uM; HL60; HT_HG-U133A | 4.37e-05 | 190 | 112 | 7 | 1172_DN | |
| Drug | Piperacetazine [3819-00-9]; Up 200; 9.8uM; MCF7; HT_HG-U133A | 4.52e-05 | 191 | 112 | 7 | 3574_UP | |
| Drug | Megestrol acetate [595-33-5]; Up 200; 10.4uM; MCF7; HT_HG-U133A | 4.67e-05 | 192 | 112 | 7 | 5013_UP | |
| Drug | Dimethisoquin hydrochloride [2773-92-4]; Up 200; 13uM; MCF7; HT_HG-U133A | 4.67e-05 | 192 | 112 | 7 | 2807_UP | |
| Drug | 0393-0188; Up 200; 10uM; PC3; HT_HG-U133A | 4.67e-05 | 192 | 112 | 7 | 7536_UP | |
| Drug | Isoquinoline, 6,7-dimethoxy-1-methyl-1,2,3,4-tetrahydro, hydrochloride; Down 200; 16.4uM; MCF7; HT_HG-U133A | 4.98e-05 | 194 | 112 | 7 | 2824_DN | |
| Drug | Tocopherol (R,S) [10191-41-0]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 4.98e-05 | 194 | 112 | 7 | 4961_UP | |
| Drug | PF-01378883-00 [351320-41-7]; Up 200; 10uM; PC3; HT_HG-U133A | 4.98e-05 | 194 | 112 | 7 | 6368_UP | |
| Drug | Doxylamine succinate [562-10-7]; Down 200; 10.2uM; PC3; HT_HG-U133A | 5.15e-05 | 195 | 112 | 7 | 4235_DN | |
| Drug | Trimethobenzamide hydrochloride [554-92-7]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 5.15e-05 | 195 | 112 | 7 | 4180_DN | |
| Drug | Finasteride [98319-26-7]; Down 200; 10.8uM; PC3; HT_HG-U133A | 5.15e-05 | 195 | 112 | 7 | 4300_DN | |
| Drug | haloperidol; Down 200; 10uM; MCF7; HT_HG-U133A | 5.32e-05 | 196 | 112 | 7 | 5604_DN | |
| Drug | Dizocilpine maleate [77086-22-7]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 5.32e-05 | 196 | 112 | 7 | 2232_DN | |
| Drug | Tetramisole hydrochloride [16595-80-5]; Down 200; 16.6uM; PC3; HT_HG-U133A | 5.32e-05 | 196 | 112 | 7 | 4587_DN | |
| Drug | Amikacin hydrate [37517-28-5]; Up 200; 6.6uM; PC3; HT_HG-U133A | 5.32e-05 | 196 | 112 | 7 | 6715_UP | |
| Drug | ICI182,780; Up 200; 1uM; PC3; HT_HG-U133A | 5.49e-05 | 197 | 112 | 7 | 7495_UP | |
| Drug | PF-00539745-00 [351321-33-0]; Up 200; 10uM; PC3; HT_HG-U133A | 5.49e-05 | 197 | 112 | 7 | 5939_UP | |
| Drug | genistein; Down 200; 10uM; HL60; HT_HG-U133A | 5.49e-05 | 197 | 112 | 7 | 2695_DN | |
| Drug | PHA-00745360 [351320-33-7]; Down 200; 10uM; PC3; HT_HG-U133A | 5.49e-05 | 197 | 112 | 7 | 3824_DN | |
| Drug | Phenethicillin potassium salt [132-93-4]; Down 200; 10uM; MCF7; HT_HG-U133A | 5.49e-05 | 197 | 112 | 7 | 6105_DN | |
| Drug | Moroxidine hydrochloride [3160-91-6]; Up 200; 19.2uM; PC3; HT_HG-U133A | 5.49e-05 | 197 | 112 | 7 | 6705_UP | |
| Drug | C75; Down 200; 10uM; PC3; HT_HG-U133A | 5.49e-05 | 197 | 112 | 7 | 6428_DN | |
| Drug | Alprostadil [745-65-3]; Down 200; 11.2uM; PC3; HT_HG-U133A | 5.67e-05 | 198 | 112 | 7 | 4099_DN | |
| Drug | Tacrine hydrochloride hydrate [1684-40-8]; Up 200; 15.8uM; PC3; HT_HG-U133A | 5.67e-05 | 198 | 112 | 7 | 6698_UP | |
| Drug | Doxycycline hydrochloride [10592-13-9]; Up 200; 8.4uM; MCF7; HT_HG-U133A | 5.67e-05 | 198 | 112 | 7 | 3479_UP | |
| Drug | iloprost; Down 200; 1uM; SKMEL5; HG-U133A | 5.67e-05 | 198 | 112 | 7 | 496_DN | |
| Drug | Bendroflumethiazide [73-48-3]; Down 200; 9.4uM; HL60; HT_HG-U133A | 5.67e-05 | 198 | 112 | 7 | 2555_DN | |
| Drug | Promazine hydrochloride [53-60-1]; Up 200; 12.4uM; HL60; HT_HG-U133A | 5.67e-05 | 198 | 112 | 7 | 2173_UP | |
| Drug | Aztreonam [78110-38-0]; Up 200; 9.2uM; PC3; HT_HG-U133A | 5.67e-05 | 198 | 112 | 7 | 5110_UP | |
| Drug | Famotidine [76824-35-6]; Down 200; 11.8uM; PC3; HT_HG-U133A | 5.85e-05 | 199 | 112 | 7 | 6665_DN | |
| Drug | SC-58125; Up 200; 10uM; MCF7; HG-U133A | 5.85e-05 | 199 | 112 | 7 | 254_UP | |
| Drug | Furazolidone [67-45-8]; Up 200; 17.8uM; MCF7; HT_HG-U133A | 5.85e-05 | 199 | 112 | 7 | 4178_UP | |
| Drug | haloperidol; Up 200; 10uM; MCF7; HT_HG-U133A | 6.04e-05 | 200 | 112 | 7 | 6963_UP | |
| Drug | Aminopurine, 6-benzyl [1214-39-7]; Up 200; 17.8uM; MCF7; HT_HG-U133A | 6.04e-05 | 200 | 112 | 7 | 3623_UP | |
| Drug | Taylor's blue | 8.96e-05 | 18 | 112 | 3 | CID000123898 | |
| Drug | thioridazine hydrochloride; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 1.24e-04 | 156 | 112 | 6 | 1010_UP | |
| Drug | Niclosamide [50-65-7]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 1.57e-04 | 163 | 112 | 6 | 1498_UP | |
| Drug | 1,3,2-dioxaborolan-2-ol | 1.64e-04 | 104 | 112 | 5 | CID005289333 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.68e-04 | 165 | 112 | 6 | 2835_DN | |
| Drug | tamibarotene | CDK8 USP9X GATA2 IRF7 BCL2 SEC31A AXIN1 NCOR2 CLTB ANKRD17 FUT4 | 1.74e-04 | 596 | 112 | 11 | ctd:C061133 |
| Drug | Ciclopirox ethanolamine [41621-49-2]; Up 200; 15uM; PC3; HT_HG-U133A | 1.79e-04 | 167 | 112 | 6 | 6677_UP | |
| Drug | Cycloheximide [66-81-9]; Down 200; 14.2uM; HL60; HT_HG-U133A | 2.04e-04 | 171 | 112 | 6 | 2723_DN | |
| Drug | SAHA; Down 200; 10uM; HL60; HT_HG-U133A | 2.31e-04 | 175 | 112 | 6 | 1161_DN | |
| Drug | SC-203048 | 2.38e-04 | 5 | 112 | 2 | ctd:C572332 | |
| Drug | idoxifene | 2.38e-04 | 5 | 112 | 2 | ctd:C071362 | |
| Drug | Carboplatin | 2.42e-04 | 113 | 112 | 5 | ctd:D016190 | |
| Drug | Parthenolide [20554-84-1]; Down 200; 16.2uM; HL60; HG-U133A | 2.53e-04 | 178 | 112 | 6 | 1736_DN | |
| Drug | Alexidine dihydrochloride [22573-93-9]; Up 200; 6.8uM; MCF7; HT_HG-U133A | 2.61e-04 | 179 | 112 | 6 | 4721_UP | |
| Drug | Propofol [2078-54-8]; Up 200; 22.4uM; MCF7; HT_HG-U133A | 2.69e-04 | 180 | 112 | 6 | 5306_UP | |
| Drug | H-7 dihydrochloride; Down 200; 100uM; PC3; HT_HG-U133A | 2.85e-04 | 182 | 112 | 6 | 5941_DN | |
| Drug | Dimaprit dihydrochloride [23256-33-9]; Down 200; 17uM; HL60; HT_HG-U133A | 2.85e-04 | 182 | 112 | 6 | 3141_DN | |
| Drug | Adiphenine hydrochloride [50-42-0]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 2.94e-04 | 183 | 112 | 6 | 1709_DN | |
| Drug | Doxorubicin hydrochloride [25316-40-9]; Down 200; 6.8uM; PC3; HT_HG-U133A | 3.02e-04 | 184 | 112 | 6 | 4610_DN | |
| Drug | 2-propylpentanoic acid; Down 200; 1000uM; HL60; HT_HG-U133A | 3.30e-04 | 187 | 112 | 6 | 2669_DN | |
| Drug | Rescinnamin [24815-24-5]; Up 200; 6.4uM; MCF7; HT_HG-U133A | 3.39e-04 | 188 | 112 | 6 | 4386_UP | |
| Drug | H-7 dihydrochloride; Down 200; 100uM; MCF7; HT_HG-U133A | 3.49e-04 | 189 | 112 | 6 | 5936_DN | |
| Drug | Mepenzolate bromide [76-90-4]; Up 200; 9.6uM; PC3; HT_HG-U133A | 3.49e-04 | 189 | 112 | 6 | 4304_UP | |
| Drug | Strophantine octahydrate [11018-89-6]; Down 200; 5.4uM; PC3; HT_HG-U133A | 3.59e-04 | 190 | 112 | 6 | 6680_DN | |
| Drug | LY294002; Up 200; 10uM; MCF7; HG-U133A | 3.59e-04 | 190 | 112 | 6 | 328_UP | |
| Drug | Phthalylsulfathiazole [85-73-4]; Down 200; 10uM; MCF7; HT_HG-U133A | 3.59e-04 | 190 | 112 | 6 | 5614_DN | |
| Drug | 17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 3.69e-04 | 191 | 112 | 6 | 998_DN | |
| Drug | 17-DMAG; Down 200; 0.1uM; PC3; HT_HG-U133A | 3.69e-04 | 191 | 112 | 6 | 4437_DN | |
| Drug | Methapyrilene hydrochloride [135-23-9]; Down 200; 13.4uM; PC3; HT_HG-U133A | 3.69e-04 | 191 | 112 | 6 | 6644_DN | |
| Drug | Desipramine hydrochloride [58-28-6]; Up 200; 13.2uM; PC3; HT_HG-U133A | 3.69e-04 | 191 | 112 | 6 | 6693_UP | |
| Drug | Beta-Escin [11072-93-8]; Down 200; 3.2uM; MCF7; HT_HG-U133A | 3.69e-04 | 191 | 112 | 6 | 3890_DN | |
| Drug | Niclosamide [50-65-7]; Down 200; 12.2uM; PC3; HT_HG-U133A | 3.79e-04 | 192 | 112 | 6 | 4018_DN | |
| Drug | troglitazone; Up 200; 10uM; MCF7; HT_HG-U133A | 3.90e-04 | 193 | 112 | 6 | 6949_UP | |
| Drug | Hydrastinine hydrochloride [4884-68-8]; Up 200; 16.4uM; MCF7; HT_HG-U133A | 3.90e-04 | 193 | 112 | 6 | 2283_UP | |
| Drug | PF-00562151-00 [351320-12-2]; Up 200; 10uM; PC3; HT_HG-U133A | 3.90e-04 | 193 | 112 | 6 | 5922_UP | |
| Drug | Cyclacillin [3485-14-1]; Up 200; 11.8uM; PC3; HT_HG-U133A | 3.90e-04 | 193 | 112 | 6 | 4536_UP | |
| Drug | 17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A | 3.90e-04 | 193 | 112 | 6 | 5215_DN | |
| Drug | Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A | 3.90e-04 | 193 | 112 | 6 | 5602_DN | |
| Drug | Rapamycin; Up 200; 0.1uM; MCF7; HT_HG-U133A | 4.01e-04 | 194 | 112 | 6 | 7001_UP | |
| Drug | Diltiazem hydrochloride [33286-22-5]; Up 200; 8.8uM; PC3; HT_HG-U133A | 4.01e-04 | 194 | 112 | 6 | 6710_UP | |
| Drug | Dimenhydrinate [523-87-5]; Down 200; 8.6uM; MCF7; HT_HG-U133A | 4.01e-04 | 194 | 112 | 6 | 5450_DN | |
| Drug | 0317956-0000 [391210-11-0]; Down 200; 10uM; PC3; HT_HG-U133A | 4.01e-04 | 194 | 112 | 6 | 4331_DN | |
| Disease | ventricular septal defect (is_implicated_in) | 1.59e-05 | 14 | 106 | 3 | DOID:1657 (is_implicated_in) | |
| Disease | Tetralogy of Fallot | 2.44e-05 | 16 | 106 | 3 | C0039685 | |
| Disease | Adenocarcinoma of large intestine | 2.56e-05 | 96 | 106 | 5 | C1319315 | |
| Disease | Feeding difficulties | 3.54e-05 | 18 | 106 | 3 | C0232466 | |
| Disease | Metastatic melanoma | 4.33e-05 | 54 | 106 | 4 | C0278883 | |
| Disease | ATRIAL FIBRILLATION, FAMILIAL, 1 (disorder) | 6.60e-05 | 22 | 106 | 3 | C1843687 | |
| Disease | CONOTRUNCAL HEART MALFORMATIONS | 7.63e-05 | 4 | 106 | 2 | 217095 | |
| Disease | Conotruncal heart malformations | 7.63e-05 | 4 | 106 | 2 | cv:C1857586 | |
| Disease | Acute Myeloid Leukemia, M1 | 9.06e-05 | 125 | 106 | 5 | C0026998 | |
| Disease | Acute Myeloid Leukemia (AML-M2) | 9.06e-05 | 125 | 106 | 5 | C1879321 | |
| Disease | anodontia (is_implicated_in) | 1.27e-04 | 5 | 106 | 2 | DOID:13714 (is_implicated_in) | |
| Disease | Klatskin's tumor (is_implicated_in) | 1.27e-04 | 5 | 106 | 2 | DOID:4927 (is_implicated_in) | |
| Disease | laryngeal carcinoma (is_marker_for) | 1.90e-04 | 6 | 106 | 2 | DOID:2600 (is_marker_for) | |
| Disease | CONOTRUNCAL HEART MALFORMATIONS (disorder) | 1.90e-04 | 6 | 106 | 2 | C1857586 | |
| Disease | Intellectual Disability | 2.15e-04 | 447 | 106 | 8 | C3714756 | |
| Disease | Swyer Syndrome | 2.65e-04 | 7 | 106 | 2 | C2936694 | |
| Disease | hereditary ataxia (implicated_via_orthology) | 2.65e-04 | 7 | 106 | 2 | DOID:0050951 (implicated_via_orthology) | |
| Disease | Gonadal Dysgenesis, 46,XY | 3.53e-04 | 8 | 106 | 2 | C0018054 | |
| Disease | AUTISM, SUSCEPTIBILITY TO, 15 | 3.53e-04 | 8 | 106 | 2 | C2677504 | |
| Disease | reticulocyte count | ARID3A USP9X CD2AP BCL2 ADCY8 MAP3K1 TBC1D8 ZFP36L2 CPEB4 MMP13 TNS1 FERMT3 | 3.78e-04 | 1045 | 106 | 12 | EFO_0007986 |
| Disease | Leukemia, Myelocytic, Acute | 4.11e-04 | 173 | 106 | 5 | C0023467 | |
| Disease | Anorectal Malformations | 4.35e-04 | 41 | 106 | 3 | C3495676 | |
| Disease | Ostium secundum atrial septal defect | 4.53e-04 | 9 | 106 | 2 | C0344724 | |
| Disease | 46,XY partial gonadal dysgenesis | 6.88e-04 | 11 | 106 | 2 | C4510744 | |
| Disease | chronic kidney disease, Proteinuria | 6.88e-04 | 11 | 106 | 2 | EFO_0003884, HP_0000093 | |
| Disease | total cholesterol measurement, triglyceride measurement, low density lipoprotein cholesterol measurement, high density lipoprotein cholesterol measurement | 7.36e-04 | 49 | 106 | 3 | EFO_0004530, EFO_0004574, EFO_0004611, EFO_0004612 | |
| Disease | acute myeloid leukemia (is_marker_for) | 7.36e-04 | 49 | 106 | 3 | DOID:9119 (is_marker_for) | |
| Disease | myeloid leukemia (is_implicated_in) | 9.72e-04 | 13 | 106 | 2 | DOID:8692 (is_implicated_in) | |
| Disease | Colorectal Carcinoma | 9.80e-04 | 702 | 106 | 9 | C0009402 | |
| Disease | familial atrial fibrillation (is_implicated_in) | 1.13e-03 | 14 | 106 | 2 | DOID:0050650 (is_implicated_in) | |
| Disease | Diabetes Mellitus, Non-Insulin-Dependent | 1.24e-03 | 221 | 106 | 5 | C0011860 | |
| Disease | Muscular Atrophy | 1.30e-03 | 15 | 106 | 2 | C0026846 | |
| Disease | Generalized hypotonia | 1.30e-03 | 15 | 106 | 2 | C1858120 | |
| Disease | Neurogenic Muscular Atrophy | 1.30e-03 | 15 | 106 | 2 | C0270948 | |
| Disease | PROSTATE CANCER, HEREDITARY, 1 | 1.33e-03 | 60 | 106 | 3 | C4722327 | |
| Disease | teratocarcinoma-derived growth factor 1 measurement | 1.48e-03 | 16 | 106 | 2 | EFO_0008297 | |
| Disease | syndromic intellectual disability (implicated_via_orthology) | 1.48e-03 | 16 | 106 | 2 | DOID:0050888 (implicated_via_orthology) | |
| Disease | Cardiovascular Abnormalities | 1.48e-03 | 16 | 106 | 2 | C0243050 | |
| Disease | Prostate cancer, familial | 1.99e-03 | 69 | 106 | 3 | C2931456 | |
| Disease | end stage renal disease (implicated_via_orthology) | 2.33e-03 | 20 | 106 | 2 | DOID:783 (implicated_via_orthology) | |
| Disease | lung cancer (is_implicated_in) | 2.43e-03 | 74 | 106 | 3 | DOID:1324 (is_implicated_in) | |
| Disease | Craniofacial Abnormalities | 2.46e-03 | 156 | 106 | 4 | C0376634 | |
| Disease | glucose measurement | 2.54e-03 | 380 | 106 | 6 | EFO_0004468 | |
| Disease | Retinal Degeneration | 2.57e-03 | 21 | 106 | 2 | C0035304 | |
| Disease | Disproportionate short stature | 2.72e-03 | 77 | 106 | 3 | C0878659 | |
| Disease | liver cirrhosis (is_marker_for) | 3.25e-03 | 82 | 106 | 3 | DOID:5082 (is_marker_for) | |
| Disease | congenital diaphragmatic hernia (biomarker_via_orthology) | 3.35e-03 | 24 | 106 | 2 | DOID:3827 (biomarker_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VPGLAAHPGSHSDQP | 86 | A8MUN3 | |
| PAGGGPNHHAPQLSG | 71 | P40145 | |
| PHGSLGHAGLPQSPA | 1081 | O00555 | |
| AAHPASNPFGPSAHP | 656 | Q9HCM7 | |
| GGTGSELHHFPPTSP | 116 | Q6ZU80 | |
| HGFPPTLGGHSFEPS | 301 | O95076 | |
| QQHHGNSGPPPPGAF | 501 | P54259 | |
| LPGRFNGGHSPTHSP | 501 | Q9Y5K6 | |
| AGGPIFNGPHAADPS | 2551 | O75179 | |
| TGGIGDSRPPSFHPH | 106 | Q92997 | |
| DSRPPSFHPHAGGGS | 111 | Q92997 | |
| SPFAAPGPQHGIAHA | 271 | Q96NX9 | |
| GHGPFSGFPGPQEHT | 6 | Q9Y463 | |
| HPGHQPGSAGQSPDL | 316 | P43699 | |
| HGAQGKPSPDAGPHG | 16 | Q96D15 | |
| GPAPHTPLASAGFGH | 266 | A6NCS4 | |
| HFRGHPALSGSPDPQ | 206 | A6NNM3 | |
| HFRGHPALSGSPDPQ | 206 | A6NJZ7 | |
| PIPAQHHFSSGIPAG | 931 | Q9H3S7 | |
| HSEGNGASGLPHYPP | 26 | P50221 | |
| GTLPPPSHGAFSGHH | 376 | Q6DT37 | |
| PTPDQGASSHGPGHA | 106 | Q9P286 | |
| HGAPFAGHLPRGSPV | 1546 | Q9Y618 | |
| SHVAPQDHGSPAGYP | 281 | Q13469 | |
| PSGLPHPGLVAAAAH | 211 | Q01851 | |
| PAAPGKQPGRGHTHA | 186 | Q8IYF1 | |
| GPPLSNGHRPAAHDF | 291 | O43474 | |
| GSAFGHSPPLIHPAP | 371 | P10071 | |
| QHAPGPGGAAHPAQA | 251 | Q9GZN0 | |
| HLPHNSLPPGSGLGT | 1571 | Q8NEZ4 | |
| GSFHGVFPGPPASSH | 11 | Q8WZ33 | |
| HLGPQHLPPGSSTSG | 286 | Q86UW9 | |
| HGTPGPEGNHISDLP | 1246 | Q9P2D0 | |
| GQGPRPLHSGTAPFH | 71 | P22083 | |
| LQVAAPAHSHAGGPG | 181 | Q15528 | |
| PGGSYSHPHHPQSPL | 1411 | Q5JU85 | |
| GLQPNPGDPSAGHHS | 1176 | Q12766 | |
| PPHLAGSPGIAASFH | 281 | P58166 | |
| AHAFPPGPNYGGDAH | 186 | P45452 | |
| TGTPFGPPPHHSNFL | 721 | Q8WXX7 | |
| LAGQGHSASPHGPPR | 786 | Q9UQ05 | |
| TQGGSALGHHSPPEP | 416 | Q13651 | |
| QGGPPGPFLAHTHAG | 151 | Q92985 | |
| GQPGHPNTGGAAAHP | 16 | Q96S07 | |
| GPAPAGSPSQHQFHP | 151 | Q5XG87 | |
| PSAFKGPSHSGNPSH | 616 | Q86XN7 | |
| PSVHKPSAGQGHPSA | 2411 | Q8NFC6 | |
| GTIQSPGHPNVYPHG | 941 | O60494 | |
| PTAAHSGSHLFGFPP | 161 | P23769 | |
| SSYASHPFGAPHGPS | 81 | Q92908 | |
| HPFGAPHGPSAPGVA | 86 | Q92908 | |
| DPAHVSHAPSGAPGQ | 111 | Q658K8 | |
| AAPGAHGPFLSPSTH | 156 | Q9HAH7 | |
| LGSQHSGAPSAAGPP | 16 | Q8IZ08 | |
| GSLGSVAPPPGGHSH | 86 | Q6P531 | |
| SPGPGHRSPDSGHVA | 486 | O15169 | |
| GHFVGPRGPHPSQFE | 1921 | Q9BTC0 | |
| PYSHSANLAPPGPGH | 126 | O75064 | |
| QTPGPHPGHQLLLFG | 196 | Q8NEP7 | |
| PHHVSPGFGGSFSPQ | 211 | Q17RY0 | |
| GHPGNQDSSHTQGPP | 386 | P49336 | |
| LAGSPAPSGHPKAGH | 481 | Q9NZT2 | |
| NTHFKAPAFHTGGPP | 31 | Q10571 | |
| PPPHGAASRGGAHLT | 111 | Q13233 | |
| DSGQGAPPHGSPALL | 511 | Q9Y2I2 | |
| THPPGHPGQQGYVVS | 351 | P0C091 | |
| SPGNHGNHYSDGPNP | 986 | Q93008 | |
| GHTHSHPSPGNPGYM | 221 | Q9Y651 | |
| YPGQHGPAHPAFSIG | 126 | Q16650 | |
| GLPPTHSEAGSQPHG | 266 | Q12972 | |
| VSPGPASGVPHHGES | 2326 | A2VEC9 | |
| APPHSPGQAGGHASD | 121 | Q7L2K0 | |
| HFRGHPALSGSPDPQ | 206 | Q9UFD9 | |
| GFAAPHGLATPHPNS | 131 | Q8IYJ0 | |
| PPTVNGYHASGTPAH | 126 | O60861 | |
| GYHASGTPAHPPETA | 131 | O60861 | |
| SASGPAAGGHHQPLH | 451 | Q92786 | |
| PALGKSPPHHSGFQQ | 776 | Q92540 | |
| PVPSSSGGDAHVPHG | 821 | Q5JRX3 | |
| PSPGTSAPGHALHGK | 576 | Q14524 | |
| SPFHAPAQSPGLHGG | 626 | A0A0B4J2F2 | |
| SPFHAPAQSPGLHGG | 626 | P57059 | |
| PRAHPAGSFHAGPGD | 81 | Q96JF0 | |
| HFHSGGMPAPASPNR | 281 | B1ATL7 | |
| VHSPGEHSGQSQGPP | 221 | P48436 | |
| GSPVHSPGSHYPHGG | 2021 | Q9UHV7 | |
| HSPGGAQAPTNLSGP | 11 | O00570 | |
| AGPHFNPLSRKHGGP | 61 | P00441 | |
| SFAPGGASRGHPIPH | 876 | Q15424 | |
| GAAPAPGIFSSQPGH | 41 | P10415 | |
| GPAHPGGAAHVAPQL | 201 | Q99856 | |
| AHPAPGLGDGHTQGP | 111 | Q9BXL8 | |
| GTVNGGHPPSALAPA | 76 | Q99967 | |
| HAAPAQPGPTSGAGS | 51 | P09497 | |
| LFPGLHEQGAGHPSP | 161 | O60481 | |
| GPPSSNGTAAHPHAH | 831 | Q5W0Q7 | |
| RGASQASGPLPGPHF | 186 | Q15654 | |
| GHAFPSPLDPGHSSV | 176 | P60852 | |
| AHLGHVFPDGPGPNG | 151 | Q9Y3D2 | |
| LGGDAGSPAPPFHSS | 891 | O95428 | |
| SPGPPVGSHHAFFSD | 736 | O95759 | |
| GSPSAAGPGFPAALH | 1081 | O94964 | |
| SNAPGPPLHIGASHL | 216 | Q9H0E3 | |
| PAEASGSGPGSPHLH | 291 | Q9C0C2 | |
| TPGSPSLGRHPGAHQ | 1266 | Q9HBL0 | |
| LPPNGHPGHVSSYSA | 301 | P56693 | |
| LPHPSVSHGNGDQGP | 1951 | Q68DE3 | |
| GPGNHPHGPDASAEG | 486 | Q86UX7 | |
| GAPHGAPHSDSPLGF | 6 | Q16473 | |
| SPPLAAQSPEGNHGH | 181 | Q9NWS9 | |
| PIPGFHAGNQLHPGN | 106 | Q86UQ0 | |
| ASFQHGGPGAPPSSS | 951 | O94979 | |
| SFPQPHLPGGQPFHG | 1051 | O94979 | |
| SGFPSGHHQPPGGLE | 261 | P47974 | |
| GSRANPGDPQPHFSH | 641 | Q9Y334 | |
| TNTRPGAHPPEHGGV | 91 | Q6ZTI0 | |
| GAHPPEHGGVAALPA | 96 | Q6ZTI0 | |
| LASGPQAAGASPHPH | 1236 | Q702N8 | |
| SFPHPLPSLTGGHGG | 396 | Q15637 | |
| ASPSPPAHAEHGGVL | 476 | O75385 | |
| SLHPRPGEGPGHSAS | 451 | Q9P2Y4 | |
| GSALASAGDPGHPNH | 1856 | O95071 | |
| VGPHFPAAPARHGSL | 521 | Q6ZMS7 | |
| PGVPPSANAHHLFRG | 361 | Q15349 |